<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02123797</url>
  </required_header>
  <id_info>
    <org_study_id>The Milestone Project</org_study_id>
    <nct_id>NCT02123797</nct_id>
  </id_info>
  <brief_title>Building a Multidisciplinary Bridge Across the Quality Chasm in Thoracic Oncology</brief_title>
  <official_title>Building a Multidisciplinary Bridge Across the Quality Chasm in Thoracic Oncology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baptist Memorial Health Care Corporation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Baptist Memorial Health Care Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lung cancer kills 160,000 patients annually; this represents 28% of all US cancer deaths. The
      overall year survival rate has only improved from 12% to 17% in 33 years. This failure
      reflects the innate lethality of lung cancer, but also reflects defects in patient care
      delivery. Care for the lung cancer patient starts with an abnormal radiologic scan, proceeds
      through a diagnostic biopsy, tests to determine the extent of spread of the disease (stage),
      selection of appropriate treatment, and finally ends with patient outcomes. At each step are
      multiple options and independent specialists, each one engaged by a process of sequential
      referrals in the serial care model. This process is often not user-friendly, is riddled with
      inefficiency, delays, and outcome variances.

      The coordinated multidisciplinary model, in which patients and their doctors collaborate to
      provide evidence-based care, is believed by experts to be superior, but has few examples of
      successful implementation. The implementation gap exists because of the paucity of good
      quality data, and lack of implementation know-how.

      Embedded in the highest US lung cancer mortality zone, the greater Memphis area has a
      racially, culturally, economically and geographically diverse population. The investigators
      research group has shown how poor quality care impairs patient survival in this region and in
      the greater US. The investigators have linked patient survival to compliance with
      multidisciplinary care plans. In this project, the investigators propose to rigorously test
      the impact of the multidisciplinary care model on patient outcomes in a community-based,
      private practice environment, similar to where 70% of lung cancer care is delivered in the
      US.

      The objective of this study is to provide high-level evidence of the impact of
      multidisciplinary care on lung cancer patient outcomes. Multidisciplinary care is defined as
      a model of care in which patients, their care-givers and key specialists concurrently and
      directly evaluate the same patients in the presence of the patients and their informal
      caregivers, in order to develop evidence-based consensus care plans
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Within the Baptist Memorial Health Care system, the Multidisciplinary Thoracic Oncology
      Program has two components: Primarily, the program is centered in a multidisciplinary clinic,
      wherein patients and their informal caregivers are seen by multiple specialists at a single
      appointment time; secondarily, the program includes a multidisciplinary conference, wherein
      all of the specialists potentially involved in lung cancer care discuss patients referred for
      presentation and make consensus recommendations for care. This study focuses primarily on the
      experience and outcomes of care delivered to patients evaluated in the multidisciplinary
      clinic. However, data from the conference will also be included in some aspects of the study.
      The goal is to improve the access and quality of thoracic oncologic care delivery within the
      Baptist Healthcare System The investigators specific aim is to perform a prospective, matched
      cohort comparative effectiveness study of patients receiving serial vs. multidisciplinary
      care, with key patient-centered endpoints (survival, stakeholder satisfaction with the care
      experience, timeliness and stage-appropriateness of care, quality of staging). Serial care is
      defined as the current system of linear, sequential, referral-based care delivery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 9, 2014</start_date>
  <completion_date type="Actual">February 29, 2020</completion_date>
  <primary_completion_date type="Actual">October 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Thoroughness of Invasive Staging, Multidisciplinary (MD) vs Serial Care (SC)</measure>
    <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
    <description>Number of patients with a test that provides tissue confirmation of the stage-defining lesion. Tests include a biopsy of any identified suspicious metastatic lesion or the primary lesion in the absence of any other suspicious lesion. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thoroughness of Invasive Mediastinal Staging, MD vs SC</measure>
    <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
    <description>Number of patients with a test (i.e., biopsy) that provides tissue confirmation of the presence or absence of mediastinal nodal metastasis. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thoroughness of Bi-Modal Staging Practice, MD vs SC</measure>
    <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
    <description>Number of patients receiving two forms of staging tests (bi-modal staging). Bi-modal staging is defined as a CT scan plus any other type of radiologic scan or any biopsy. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thoroughness of Tri-Modal Staging Practice, MD vs SC</measure>
    <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
    <description>Number of patients receiving three forms of staging tests (tri-modal staging). Tri-modal staging is defined as a CT scan plus any other type of radiologic scan plus any biopsy, or PET/CT plus any biopsy. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thoroughness of Invasive Staging, MD vs SC (Conference) vs SC (no Conference)</measure>
    <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
    <description>Number of patients with a test that provides tissue confirmation of the stage-defining lesion. Tests include a biopsy of any identified suspicious metastatic lesion or the primary lesion in the absence of any other suspicious lesion.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thoroughness of Invasive Mediastinal Staging, MD vs SC (no Conference) vs SC (Conference)</measure>
    <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
    <description>Number of patients with a test (i.e., biopsy) that provides tissue confirmation of the presence or absence mediastinal nodal metastasis.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thoroughness of Bi-Modal Staging Practice, MD vs SC (Conference) vs SC (no Conference)</measure>
    <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
    <description>Number of patients receiving two forms of staging tests (bi-modal staging). Bi-modal staging is defined as a CT scan plus any other type of radiologic scan or any biopsy.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thoroughness of Tri-Modal Staging Practice, MD vs SC (Conference) vs SC (no Conference)</measure>
    <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
    <description>Number of patients receiving three forms of staging tests (tri-modal staging). Tri-modal staging is defined as a CT scan plus any other type of radiologic scan plus any biopsy, or PET/CT plus any biopsy.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stage-Appropriateness Treatment Selection, MD vs SC</measure>
    <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
    <description>Number of patients for whom appropriate treatment was given, as determined by the patients' clinical stage and treatment guidelines stipulated by the National Comprehensive Cancer Network (NCCN). 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.
For Stage I or II: surgery (or radiation therapy with documented contraindication to surgery or patient refusal); for Stage III: chemotherapy and radiation therapy with or without surgery; for Stage IV: systemic therapy (or palliative care with documented patient refusal or contraindication to systemic therapy).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stage-Appropriateness Treatment Selection, MD vs SC (Conference) vs SC (no Conference)</measure>
    <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
    <description>Number of patients for whom appropriate treatment was given, as determined by the patients' clinical stage and treatment guidelines stipulated by the National Comprehensive Cancer Network (NCCN).
For Stage I or II: surgery (or radiation therapy with documented contraindication to surgery or patient refusal); for Stage III: chemotherapy and radiation therapy with or without surgery; for Stage IV: systemic therapy (or palliative care with documented patient refusal or contraindication to systemic therapy).
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Timeliness of Communication, MD vs SC(Conference)</measure>
    <time_frame>Within 48 hours of a documented care recommendation made through the multidisciplinary thoracic oncology program</time_frame>
    <description>Number of patients for whom formal, verified communication of care management decisions was made to all team members (providers inside and outside the multidisciplinary program, patients and their care-givers) within 48 hours of a care recommendation being made. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concordance Rate for Initial Conference Recommendations, MD vs SC (Conference)</measure>
    <time_frame>From the time of a patient's positive lung cancer diagnosis, to the end of a patient's last line of treatment, an average of 1-2 months</time_frame>
    <description>Number of patients for whom all recommendations made at the initial multidisciplinary conference were completed. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients. Note that two patients (one from the MD arm and one from the SC arm) have died before receiving recommendations and therefore were not analyzed for this outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concordance Rate for Initial Conference Recommendation(s) With Prior Condition Met, MD vs SC (Conference)</measure>
    <time_frame>From the time of a patient's positive lung cancer diagnosis, to the end of a patient's last line of treatment, an average of 1-2 months</time_frame>
    <description>Number of patients for whom all initial conference recommendations were completed, excluding conditional recommendations for which the prior condition was not met. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients. Note that two patients (one from the MD arm and one from the SC arm) have died before receiving recommendations and therefore were not analyzed for this outcome.
E.g., if a recommendation was to have a PET/CT and then a staging biopsy if the PET showed suspicious metastatic disease, the staging biopsy recommendation was excluded from the concordance measure if the PET/CT did not happen or was negative.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concordance Rate for Any Conference Recommendation, MD vs SC (Conference)</measure>
    <time_frame>From the time of a patient's positive lung cancer diagnosis, to the end of a patient's last line of treatment, an average of 1-2 months</time_frame>
    <description>Number of patients for whom any initial conference recommendation was completed. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients. Note that two patients (one from the MD arm and one from the SC arm) have died before receiving recommendations and therefore were not analyzed for this outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Concordance Rate Using a Hierarchy of Initial Conference Recommendations, MD vs SC (Conference)</measure>
    <time_frame>From the time of a patient's positive lung cancer diagnosis, to the end of a patient's last line of treatment, an average of 1-2 months</time_frame>
    <description>Number of patients for whom the overall initial conference recommendation was completed. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients. Note that two patients (one from the MD arm and one from the SC arm) have died before receiving recommendations and therefore were not analyzed for this outcome.
The hierarchy to rank recommendations, from highest priority to lowest, was (1) treatment, (2) staging, (3) diagnosis, (4) surveillance.
If a patient had a treatment recommendation and it happened, he/she was concordant. If treatment was recommended and it did not happen, he/she was discordant. If no treatment recommendation was made, then concordance was measured by whether or not the staging recommendation was met. If no staging recommendation was made, then the diagnostic recommendation was given priority for a concordance measurement. If no diagnostic recommendation, then a surveillance recommendation was used to measure overall concordance.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concordance Rate for Treatment Recommendations With Prior Recommendations Completed, MD vs SC (Conference)</measure>
    <time_frame>From the time of a patient's positive lung cancer diagnosis, to the end of a patient's last line of treatment, an average of 1-2 months</time_frame>
    <description>Number of patients for whom the treatment recommendation made at the initial conference presentation was completed, excluding any patient for whom prior recommendations (staging, diagnosis, surveillance) were not also completed. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Baseline Patient Survey Response Rate, MD vs SC</measure>
    <time_frame>Baseline</time_frame>
    <description>Number of patients who completed a baseline patient survey</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3-month Patient Survey Response Rate, MD vs SC</measure>
    <time_frame>Within 30 days of 3 months after baseline survey administration</time_frame>
    <description>Number of patients who completed a 3-month survey</description>
  </primary_outcome>
  <primary_outcome>
    <measure>6-Month Patient Survey Response Rate, MD vs SC</measure>
    <time_frame>Within 30 days of 6 months after baseline survey administration</time_frame>
    <description>Number of patients who completed a 6-month survey</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Survey Scores at Baseline, MD vs SC</measure>
    <time_frame>Baseline</time_frame>
    <description>Scores from patient surveys that measure quality of life and satisfaction with care received at the time the baseline survey was taken.
Overall quality of health care - satisfaction with overall quality of health care since lung cancer diagnosis; range: 0-4 (higher is better) Financial burden of care - assessment of financial burden of care; range: 3-6 (sum of 3 items, higher is worse) Treatment decision-making: Surgery/Radiation/Chemotherapy - each 1 item; satisfaction with treatment decision-making; range: 0-2 (0=patient controlled; 1=shared decision; 2-physician decision; closer to 1 is best) Satisfaction with treatment plan - satisfaction with overall treatment plan; range: 1-5 (sum of 2 items, higher is better) Treatment decision-making: family role - satisfaction with family role in treatment decision-making; range: 0-2 (0=patient controlled; 1=shared decision; 2-physician decision; closer to 1 is best) (descriptions continued in 3 month survey description)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Survey Scores at 3 Months, MD vs SC</measure>
    <time_frame>Within 30 days of 3 months after baseline survey administration</time_frame>
    <description>Scores from patient surveys that measure quality of life and satisfaction with care received at the time the 3-month survey was taken.
(continued from baseline) Satisfaction with quality of care - overall satisfaction with care received from all care team members; range: 0-18 (sum of 6 items, higher is better) Satisfaction with physician communication - overall satisfaction with physician communication; range: 0-21 (sum of 7 items, higher is better) Satisfaction with nurse communication - overall satisfaction with nurse communication; range: 0-18 (sum of 6 items, higher is better) Overall team satisfaction - CAHPS satisfaction with care from team as a whole; range: 0-15 (sum of 4 items, higher is better) Physical/Social/Functional well-being - health-related quality of life relating to physical/social/functional well-being; range 0-28 (each a sum of 7 items, higher is better) (description continues in 6 month survey description)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Survey Scores at 6 Months, MD vs SC</measure>
    <time_frame>Within 30 days of 6 months after baseline survey administration</time_frame>
    <description>Scores from patient surveys that measure quality of life and satisfaction with care received at the time the 6-month survey was taken.
(cont) Emotional well-being - health-related quality of life related to emotional well-being; range 0-30 (sum of 6 items, higher is better) Lung cancer specific QOL - health-related quality of life related to lung cancer diagnosis; range: 0-36 (sum of 9 items, higher is better) Total Summary Score FACTL - full survey, functional assessment of cancer therapy - lung; range: 0-136 (sum of 36 items, higher is better) Generic Score FACTG - full survey, functional assessment of cancer therapy - general; range: 0-108 (sum of 27 items, higher is better) Trial Outcome Index - health related quality of life - trial outcome index; range: 0-84 (sum of 23 items, higher is better) Depression/Anxiety - depression/anxiety measured by Hospital Anxiety and Depression Scale; range: 0-21 (sum of 7 items each, higher is worse)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Baseline Caregiver Survey Response Rate, MD vs SC</measure>
    <time_frame>Baseline</time_frame>
    <description>Number of caregivers who completed a baseline patient survey</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3-month Caregiver Survey Response Rate, MD vs SC</measure>
    <time_frame>Within 30 days of 3 months after baseline survey administration</time_frame>
    <description>Number of caregivers who completed a 3-month survey</description>
  </primary_outcome>
  <primary_outcome>
    <measure>6-Month Caregiver Survey Response Rate, MD vs SC</measure>
    <time_frame>Within 30 days of 6 months after baseline survey administration</time_frame>
    <description>Number of caregivers who completed a 6-month survey</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Caregiver Survey Scores at Baseline, MD vs SC</measure>
    <time_frame>Baseline</time_frame>
    <description>Scores from caregiver surveys that measure quality of life and satisfaction with care received at the time the baseline survey was taken.
Overall quality of health care - satisfaction with overall quality of health care since lung cancer diagnosis; range:0-4 (higher is better) Treatment decision-making: Surgery/Radiation/Chemotherapy - each 1 item; satisfaction with treatment decision-making; range: 0-2 (0=patient controlled; 1=shared decision; 2-physician decision; closer to 1 is best) Treatment decision-making: family role - satisfaction with family role in treatment decision-making; range: 0-2 (0=patient controlled; 1=shared decision; 2-physician decision; closer to 1 is best) Satisfaction with treatment plan - satisfaction with overall treatment plan; range: 0-2 (higher is better) Satisfaction patient can complete treatment plan; range: 0-2 (higher is better) (continued in 3 month survey description)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Caregiver Survey Scores at 3 Months, MD vs SC</measure>
    <time_frame>Within 30 days of 3 months after baseline survey administration</time_frame>
    <description>Scores from caregiver surveys that measure quality of life and satisfaction with care received at the time the 3-month survey was taken.
(cont) Satisfaction with quality of care - overall satisfaction with care received from all care team members; range: 0-18 (sum of 6 items, higher is better) Satisfaction with physician communication - overall satisfaction with physician communication; range: 0-28 (sum of 7 items, higher is better) Satisfaction with nurse communication - overall satisfaction with nurse communication; range: 6-24 (sum of 6 items, higher is better) Overall team satisfaction - CAHPS satisfaction with care from team as a whole; range: 0-15 (sum of 4 items, higher is better) Depression/Anxiety - depression/anxiety measured by Hospital Anxiety and Depression Scale; range: 0-21 (sum of 7 items, higher is worse) (continued in 6 month survey description)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Caregiver Survey Scores at 6 Months, MD vs SC</measure>
    <time_frame>Within 30 days of 6 months after baseline survey administration</time_frame>
    <description>Scores from caregiver surveys that measure quality of life and satisfaction with care received at the time the 6-month survey was taken.
(cont) Physical Functioning QOL - 10 items; Physical Health Problems QOL - 4 items; Pain QOL - 2 items; General health perceptions - 5 items; Energy/fatigue QOL - 4 items; Social Functioning QOL - 2 items; Emotional health problems QOL - 3 items; Emotional well-being QOL - 5 items.
All health related quality of life measures are from the SF-36 survey tool, and use a range of 0-100 mean score (higher is better).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Timeliness of Care, MD vs SC</measure>
    <time_frame>From the time of a patient's initial lesion detection to the designated step in the care process, as noted per row below</time_frame>
    <description>Aggregate time in days from enrollment to a specific care delivery endpoint including: from initial detection of lesion to initial biopsy, from initial detection to non-invasive staging, from initial detection to invasive staging, and from initial detection to definitive treatment. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Timeliness of Care, MD vs SC (Conference) vs SC (no Conference)</measure>
    <time_frame>From the time of a patient's initial lesion detection to the designated step in the care process, as noted per row below</time_frame>
    <description>Aggregate time in days from enrollment to specific care delivery endpoint including: from initial detection of lesion to initial biopsy, from initial detection to non-invasive staging, from initial detection to invasive staging, and from initial detection to definitive treatment.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Provider Survey Responses - Ease of Referring Patients to the Conference</measure>
    <time_frame>After a provider referred their 5th patient to the multidisciplinary conference (baseline), then within 30 days of 6 months and 12 months, respectively, after baseline survey was completed</time_frame>
    <description>Responses from clinical providers will measure provider satisfaction and obstacles to institutional multidisciplinary care.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Provider Survey Responses - How Quickly my Patients Get Scheduled to be Discussed at the Conference</measure>
    <time_frame>After a provider referred their 5th patient to the multidisciplinary conference (baseline), then within 30 days of 6 months and 12 months, respectively, after baseline survey was completed</time_frame>
    <description>Responses from clinical providers will measure provider satisfaction and obstacles to institutional multidisciplinary care.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Provider Survey Responses - The Helpfulness of the Staff in Scheduling Patients</measure>
    <time_frame>After a provider referred their 5th patient to the multidisciplinary conference (baseline), then within 30 days of 6 months and 12 months, respectively, after baseline survey was completed</time_frame>
    <description>Responses from clinical providers will measure provider satisfaction and obstacles to institutional multidisciplinary care.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Provider Survey Responses - The Quality of Treatment Recommendations That I Received for my Patient</measure>
    <time_frame>After a provider referred their 5th patient to the multidisciplinary conference (baseline), then within 30 days of 6 months and 12 months, respectively, after baseline survey was completed</time_frame>
    <description>Responses from clinical providers will measure provider satisfaction and obstacles to institutional multidisciplinary care.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Provider Survey Responses - How Quickly I Receive Feedback on my Patient</measure>
    <time_frame>After a provider referred their 5th patient to the multidisciplinary conference (baseline), then within 30 days of 6 months and 12 months, respectively, after baseline survey was completed</time_frame>
    <description>Responses from clinical providers will measure provider satisfaction and obstacles to institutional multidisciplinary care.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Provider Survey Responses - The Consistency With Which my Patients Are Sent Back for Further Treatment</measure>
    <time_frame>After a provider referred their 5th patient to the multidisciplinary conference (baseline), then within 30 days of 6 months and 12 months, respectively, after baseline survey was completed</time_frame>
    <description>Responses from clinical providers will measure provider satisfaction and obstacles to institutional multidisciplinary care.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Overall Survival</measure>
    <time_frame>As measured from the time from cancer diagnosis to death or data censor, up to 6 years</time_frame>
    <description>Overall survival, defined as the time from cancer diagnosis to death from any cause or data censoring, is analyzed and summarized with the survival probabilities over time using the Kaplan-Meier method. Confidence intervals for the 1- and 3- year survival probabilities are reported. Additionally, the Cox proportional hazard model was used to estimate hazard ratios which are reported in the statistical analyses with 95% confidence intervals.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Overall Survival With SC Further Broken Down</measure>
    <time_frame>As measured from the time from cancer diagnosis to death or data censor, up to 6 years</time_frame>
    <description>Overall survival, defined as the time from cancer diagnosis to death from any cause or data censoring, is analyzed and summarized with the survival probabilities over time using the Kaplan-Meier method. Confidence intervals for the 1- and 3- year survival probabilities are reported. Additionally, the Cox proportional hazard model was used to estimate hazard ratios which are reported in the statistical analyses with 95% confidence intervals.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Disease/Progression Free Survival</measure>
    <time_frame>measured from the time from cancer diagnosis to disease progression, death, or data censoring, up to 6 years</time_frame>
    <description>Event-free survival (EFS), as measured from the time from cancer diagnosis to disease progression, death, or data censoring, is analyzed and summarized with the survival probabilities over time using the Kaplan-Meier method. Confidence intervals for the 1- and 3- year survival probabilities are reported. Additionally, the Cox proportional hazard model was used to estimate hazard ratios which are reported in the statistical analyses with 95% confidence intervals.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Disease/Progression Free Survival With SC Further Broken Down</measure>
    <time_frame>As measured from the time from cancer diagnosis to death or data censor, up to 6 years</time_frame>
    <description>Event-free survival (EFS), as measured from the time from cancer diagnosis to disease progression, death, or data censoring, is analyzed and summarized with the survival probabilities over time using the Kaplan-Meier method. Confidence intervals for the 1- and 3- year survival probabilities are reported. Additionally, the Cox proportional hazard model was used to estimate hazard ratios which are reported in the statistical analyses with 95% confidence intervals.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
  </primary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Actual">781</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Multidisciplinary Clinic Patients</arm_group_label>
    <description>: 150 multidisciplinary clinic patients matched 1:2 with 300 serial care patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Serial Care Patients</arm_group_label>
    <description>150 multidisciplinary clinic patients matched 1:2 with 300 serial care patients = 450 patients Since Baptist Health Care System manages &gt;800 new cases each year, 300 of which are expected to be seen in multidisciplinary clinic, in practice, we conservatively expect to be able to recruit 150 cases from multidisciplinary clinic and 300 matched serial care controls (1:2 match) in 18 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multidisciplinary Caregivers</arm_group_label>
    <description>Consenting caregivers of consented multidisciplinary clinic patients (patients seen by multiple specialists at a single appointment time).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Serial Care Caregivers</arm_group_label>
    <description>Consenting caregivers of consented serial care patients (patients who receive the current system of linear, sequential, referral-based care delivery).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clinical Providers</arm_group_label>
    <description>Clinical providers who referred at least 5 patients to the multidisciplinary program and consented to the study.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Lung Cancer Patients coming through the Baptist health care system
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - All patients who undergo care for lung cancer or an undiagnosed lung mass within the
        Baptist Memorial Health Care Corporation's hospitals from January 1, 2009 until the end of
        the defined study period will be eligible for inclusion in the data collection for this
        study. In addition, caregivers of patients within the same institution and within the study
        window, clinical care providers (doctors and nurses) who have taken care of patients within
        the eligible institutions during the study window.

        Exclusion Criteria:

          -  Patients who do not have a radiology-identified lung lesion or lung cancer are
             excluded from this study.

          -  Patients not receiving care within the Baptist Memorial Healthcare Corporation are
             excluded from this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raymond Osarogiagbon</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baptist Memorial Health Care Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Baptist Memorial Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 22, 2014</study_first_submitted>
  <study_first_submitted_qc>April 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 28, 2014</study_first_posted>
  <results_first_submitted>October 31, 2017</results_first_submitted>
  <results_first_submitted_qc>June 15, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">July 2, 2020</results_first_posted>
  <last_update_submitted>June 15, 2020</last_update_submitted>
  <last_update_submitted_qc>June 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baptist Memorial Health Care Corporation</investigator_affiliation>
    <investigator_full_name>Raymond Osarogiagbon, MD</investigator_full_name>
    <investigator_title>Director, Thoracic Oncology Research Group, Mutidisciplinary Program</investigator_title>
  </responsible_party>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 9, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/97/NCT02123797/SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form: Patient ICF</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 10, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/97/NCT02123797/ICF_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form: Care Giver ICF</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 10, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/97/NCT02123797/ICF_002.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form: Provider ICF</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 10, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/97/NCT02123797/ICF_003.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 9, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/97/NCT02123797/Prot_004.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The recruitment process included a patient population of those receiving care and/or treatment for their lung cancer from physicians and clinics within the Baptist Cancer Center network, including sites in the Memphis metropolitan area, Oxford, Mississippi, and Jonesboro, Arkansas. Dates of recruitment were from October 2014 through May 2016.</recruitment_details>
      <pre_assignment_details>Patient eligibility criteria: diagnosis of lung cancer within 6 weeks of screening date, an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2, no previous lung cancer diagnosis, and no diagnosis of other cancers within the past 5 years. Caregivers and clinical care providers (doctors/nurses) of eligible patients also gave consent.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Multidisciplinary Clinic Patients</title>
          <description>For the multidisciplinary arm, patients and their informal caregivers are seen by multiple specialists at a single appointment time.</description>
        </group>
        <group group_id="P2">
          <title>Serial Care Patients</title>
          <description>For the serial care arm, matched serial care control patients receive the current system of linear, sequential, referral-based care delivery.</description>
        </group>
        <group group_id="P3">
          <title>Multidisciplinary Caregivers</title>
          <description>Consenting caregivers of consented multidisciplinary clinic patients (patients seen by multiple specialists at a single appointment time).</description>
        </group>
        <group group_id="P4">
          <title>Serial Care Caregivers</title>
          <description>Consenting caregivers of consented serial care patients (patients who receive the current system of linear, sequential, referral-based care delivery).</description>
        </group>
        <group group_id="P5">
          <title>Clinical Providers</title>
          <description>Clinical providers who referred at least 5 patients to the multidisciplinary program and consented to the study.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Baseline Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="178"/>
                <participants group_id="P2" count="348"/>
                <participants group_id="P3" count="100"/>
                <participants group_id="P4" count="144"/>
                <participants group_id="P5" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="156"/>
                <participants group_id="P2" count="306"/>
                <participants group_id="P3" count="100"/>
                <participants group_id="P4" count="144"/>
                <participants group_id="P5" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="42"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Relocation</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Out of window for initial survey</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other Disease</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>3-month Follow up (Cumulative Counts)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="156"/>
                <participants group_id="P2" count="306"/>
                <participants group_id="P3" count="100"/>
                <participants group_id="P4" count="144"/>
                <participants group_id="P5" count="11">Clinical providers received 6 month follow-up rather than 3 month follow-up at this stage.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="99"/>
                <participants group_id="P2" count="189"/>
                <participants group_id="P3" count="50"/>
                <participants group_id="P4" count="62"/>
                <participants group_id="P5" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="57"/>
                <participants group_id="P2" count="117"/>
                <participants group_id="P3" count="50"/>
                <participants group_id="P4" count="82"/>
                <participants group_id="P5" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="57"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="50"/>
                <participants group_id="P4" count="82"/>
                <participants group_id="P5" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Relocation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Out of window for follow-up survey</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="36"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>6-month Follow up (Cumulative Counts)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="156"/>
                <participants group_id="P2" count="306"/>
                <participants group_id="P3" count="100"/>
                <participants group_id="P4" count="144"/>
                <participants group_id="P5" count="8">Clinical providers received 12 month follow-up rather than 6-month follow-up at this stage.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="101"/>
                <participants group_id="P2" count="178"/>
                <participants group_id="P3" count="34"/>
                <participants group_id="P4" count="31"/>
                <participants group_id="P5" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="55"/>
                <participants group_id="P2" count="128"/>
                <participants group_id="P3" count="66"/>
                <participants group_id="P4" count="113"/>
                <participants group_id="P5" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="97"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="66"/>
                <participants group_id="P4" count="113"/>
                <participants group_id="P5" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Relocation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Did not collect baseline information for caregivers or clinical providers since they were based on the patient information.</population>
      <group_list>
        <group group_id="B1">
          <title>Multidisciplinary Clinic Patients</title>
          <description>150 multidisciplinary clinic patients and their informal caregivers are seen by multiple specialists at a single appointment time.</description>
        </group>
        <group group_id="B2">
          <title>Serial Care Patients</title>
          <description>300 matched serial care control patients who receive the current system of linear, sequential, referral-based care delivery.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="178"/>
            <count group_id="B2" value="348"/>
            <count group_id="B3" value="526"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="147"/>
                    <measurement group_id="B3" value="202"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="123"/>
                    <measurement group_id="B2" value="201"/>
                    <measurement group_id="B3" value="324"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68.85" spread="10.34"/>
                    <measurement group_id="B2" value="65.79" spread="9.62"/>
                    <measurement group_id="B3" value="66.83" spread="9.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="93"/>
                    <measurement group_id="B2" value="167"/>
                    <measurement group_id="B3" value="260"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="85"/>
                    <measurement group_id="B2" value="181"/>
                    <measurement group_id="B3" value="266"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="164"/>
                    <measurement group_id="B2" value="308"/>
                    <measurement group_id="B3" value="472"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="65"/>
                    <measurement group_id="B2" value="99"/>
                    <measurement group_id="B3" value="164"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="110"/>
                    <measurement group_id="B2" value="247"/>
                    <measurement group_id="B3" value="357"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="178"/>
                    <measurement group_id="B2" value="348"/>
                    <measurement group_id="B3" value="526"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Primary Insurance</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Medicare</title>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="113"/>
                    <measurement group_id="B3" value="182"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Medicaid</title>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="77"/>
                    <measurement group_id="B3" value="110"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Commercial</title>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                    <measurement group_id="B2" value="147"/>
                    <measurement group_id="B3" value="213"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Self-insured/None</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Histology</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Adenocarcinoma</title>
                  <measurement_list>
                    <measurement group_id="B1" value="94"/>
                    <measurement group_id="B2" value="169"/>
                    <measurement group_id="B3" value="263"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Squamous Cell</title>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="112"/>
                    <measurement group_id="B3" value="167"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Small Cell</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="75"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ECOG</title>
          <description>Eastern Cooperative Oncology Group performance status scale. 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care; 5: dead.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>0</title>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                    <measurement group_id="B2" value="118"/>
                    <measurement group_id="B3" value="198"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1</title>
                  <measurement_list>
                    <measurement group_id="B1" value="86"/>
                    <measurement group_id="B2" value="182"/>
                    <measurement group_id="B3" value="268"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Initial Stage</title>
          <description>Initial Stage is the patient's clinical stage at initial lesion detection as determined by a radiologic scan that first showed a lesion. The staging reported uses the AJCC 7th edition Tumor/Node/Metastasis (TNM) framework for lung cancer staging. Lower staging (Stage IA) is considered a better prognosis than higher staging (Stage IV). For each stage, an earlier letter means a lower stage. Occult carcinoma means the main tumor cant be assessed. In this study, a change in clinical staging from initial to independently-calculated stage measures the impact of pre-treatment decision-making.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Stage I</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage IA</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="95"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage IB</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage II</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage IIA</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage IIB</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage IIIA</title>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="110"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage IIIB</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage IV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="132"/>
                    <measurement group_id="B3" value="171"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Occult Carcinoma</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Independently Calculated Clinical Stage</title>
          <description>Independently calculated clinical stage refers to the clinical stage immediately before the onset of first line treatment is determined. The independent calculation is performed by a trained research team member using all available pre-treatment clinical information and following the AJCC 7th edition Tumor/Node/Metastasis (TNM) guidelines for lung cancer. Lower staging (Stage 0) is considered a better prognosis than higher staging (Stage IV). Within each stage, an earlier letter means a lower stage.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Stage 0</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage IA</title>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="93"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage IB</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage IIA</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage IIB</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage IIIA</title>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="89"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage IIIB</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage IV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="152"/>
                    <measurement group_id="B3" value="204"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Independently Calculated Clinical T Category</title>
          <description>The T category measures the size and extent of the primary tumor. Lower T categories (T1 tumor 3 cm or less) are considered better prognosis than higher T categories (T4 tumor larger than 7 cm, 2+ separate tumor nodules, or growth between the lungs). Independently calculated clinical T category refers to the method by which the T category immediately before onset of first line treatment is determined. The independent calculation is performed by a trained researcher using all available pre-treatment clinical information following the AJCC 7th edition framework for lung cancer staging.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>T0</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>T1a</title>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="92"/>
                  </measurement_list>
                </category>
                <category>
                  <title>T1b</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="71"/>
                  </measurement_list>
                </category>
                <category>
                  <title>T2a</title>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="81"/>
                    <measurement group_id="B3" value="116"/>
                  </measurement_list>
                </category>
                <category>
                  <title>T2b</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
                <category>
                  <title>T3</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
                <category>
                  <title>T4</title>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="66"/>
                    <measurement group_id="B3" value="102"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Insufficient Records</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Independently Calculated Clinical N Category</title>
          <description>The N category measures the degree of cancer spread to nearby lymph nodes. Lower N categories (N0 the cancer has not spread to nearby lymph nodes) are considered better prognosis than higher N categories (N2 cancer spread to lymph nodes between the lungs). Independently calculated clinical N category refers to the method by which the N category immediately before onset of first line treatment is determined. The independent calculation is performed by a trained researcher using all available pre-treatment clinical information following the AJCC 7th edition framework for lung cancer staging.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>N0</title>
                  <measurement_list>
                    <measurement group_id="B1" value="92"/>
                    <measurement group_id="B2" value="156"/>
                    <measurement group_id="B3" value="248"/>
                  </measurement_list>
                </category>
                <category>
                  <title>N1</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
                <category>
                  <title>N2</title>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="113"/>
                    <measurement group_id="B3" value="159"/>
                  </measurement_list>
                </category>
                <category>
                  <title>N3</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="76"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Insufficient Records</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Independently Calculated Clinical M Category</title>
          <description>M category refers to the spread (metastasis) of the cancer to distant sites. Lower M categories (M0 no distant spread) are considered better prognosis than higher M categories (M1b spread outside the chest to distant organs such as liver, bones, or brain). Independently calculated clinical M category refers to the method by which the M category immediately before onset of first line treatment is determined. The independent calculation is performed by a trained researcher using all available pre-treatment clinical information following the AJCC 7th edition framework for lung cancer staging.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>M0</title>
                  <measurement_list>
                    <measurement group_id="B1" value="126"/>
                    <measurement group_id="B2" value="196"/>
                    <measurement group_id="B3" value="322"/>
                  </measurement_list>
                </category>
                <category>
                  <title>M1a</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>M1b</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="119"/>
                    <measurement group_id="B3" value="157"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Thoroughness of Invasive Staging, Multidisciplinary (MD) vs Serial Care (SC)</title>
        <description>Number of patients with a test that provides tissue confirmation of the stage-defining lesion. Tests include a biopsy of any identified suspicious metastatic lesion or the primary lesion in the absence of any other suspicious lesion. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
        <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
        <population>All Specific Aim 3 patients (patients with histologically confirmed lung cancer (irrespective of histology) and an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0 (asymptomatic) to 2 (symptomatic but out of bed for &gt;50% of the day)).</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients</title>
            <description>Patients seen and treated in the standard, sequential-referral-based environment of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Thoroughness of Invasive Staging, Multidisciplinary (MD) vs Serial Care (SC)</title>
          <description>Number of patients with a test that provides tissue confirmation of the stage-defining lesion. Tests include a biopsy of any identified suspicious metastatic lesion or the primary lesion in the absence of any other suspicious lesion. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
          <population>All Specific Aim 3 patients (patients with histologically confirmed lung cancer (irrespective of histology) and an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0 (asymptomatic) to 2 (symptomatic but out of bed for &gt;50% of the day)).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="178"/>
                <count group_id="O2" value="348"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="108"/>
                    <measurement group_id="O2" value="168"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="70"/>
                    <measurement group_id="O2" value="180"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0007</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.03</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.35</ci_lower_limit>
            <ci_upper_limit>3.06</ci_upper_limit>
            <estimate_desc>Odds ratio comparing Multidisciplinary Clinic patients with and without invasive stage confirmation (numerator=108/70) to Serial Care patients with and without invasive stage confirmation (denominator=168/180) after adjustment for matched study.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Thoroughness of Invasive Mediastinal Staging, MD vs SC</title>
        <description>Number of patients with a test (i.e., biopsy) that provides tissue confirmation of the presence or absence of mediastinal nodal metastasis. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
        <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
        <population>All Specific Aim 3 patients (patients with histologically confirmed lung cancer (irrespective of histology) and an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0 (asymptomatic) to 2 (symptomatic but out of bed for &gt;50% of the day)).</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients</title>
            <description>Patients seen and treated in the standard, sequential-referral-based environment of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Thoroughness of Invasive Mediastinal Staging, MD vs SC</title>
          <description>Number of patients with a test (i.e., biopsy) that provides tissue confirmation of the presence or absence of mediastinal nodal metastasis. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
          <population>All Specific Aim 3 patients (patients with histologically confirmed lung cancer (irrespective of histology) and an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0 (asymptomatic) to 2 (symptomatic but out of bed for &gt;50% of the day)).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="178"/>
                <count group_id="O2" value="348"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="91"/>
                    <measurement group_id="O2" value="126"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="87"/>
                    <measurement group_id="O2" value="222"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0022</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.87</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.25</ci_lower_limit>
            <ci_upper_limit>2.80</ci_upper_limit>
            <estimate_desc>Odds ratio comparing Multidisciplinary Clinic patients with and without invasive mediastinal staging (numerator=91/87) to Serial Care patients with and without mediastinal invasive staging (denominator=126/222) after adjustment for matched study.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Thoroughness of Bi-Modal Staging Practice, MD vs SC</title>
        <description>Number of patients receiving two forms of staging tests (bi-modal staging). Bi-modal staging is defined as a CT scan plus any other type of radiologic scan or any biopsy. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
        <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
        <population>All Specific Aim 3 patients (patients with histologically confirmed lung cancer (irrespective of histology) and an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0 (asymptomatic) to 2 (symptomatic but out of bed for &gt;50% of the day)).</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients</title>
            <description>Patients seen and treated in the standard, sequential-referral-based environment of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Thoroughness of Bi-Modal Staging Practice, MD vs SC</title>
          <description>Number of patients receiving two forms of staging tests (bi-modal staging). Bi-modal staging is defined as a CT scan plus any other type of radiologic scan or any biopsy. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
          <population>All Specific Aim 3 patients (patients with histologically confirmed lung cancer (irrespective of histology) and an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0 (asymptomatic) to 2 (symptomatic but out of bed for &gt;50% of the day)).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="178"/>
                <count group_id="O2" value="348"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="161"/>
                    <measurement group_id="O2" value="267"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0004</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>3.12</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.67</ci_lower_limit>
            <ci_upper_limit>5.85</ci_upper_limit>
            <estimate_desc>Odds ratio comparing Multidisciplinary Clinic patients with and without bi-modal staging (numerator=161/17) to Serial Care patients with and without bi-modal staging (denominator=267/81) after adjustment for matched study design.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Thoroughness of Tri-Modal Staging Practice, MD vs SC</title>
        <description>Number of patients receiving three forms of staging tests (tri-modal staging). Tri-modal staging is defined as a CT scan plus any other type of radiologic scan plus any biopsy, or PET/CT plus any biopsy. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
        <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
        <population>All Specific Aim 3 patients (patients with histologically confirmed lung cancer (irrespective of histology) and an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0 (asymptomatic) to 2 (symptomatic but out of bed for &gt;50% of the day)).</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients</title>
            <description>Patients seen and treated in the standard, sequential-referral-based environment of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Thoroughness of Tri-Modal Staging Practice, MD vs SC</title>
          <description>Number of patients receiving three forms of staging tests (tri-modal staging). Tri-modal staging is defined as a CT scan plus any other type of radiologic scan plus any biopsy, or PET/CT plus any biopsy. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
          <population>All Specific Aim 3 patients (patients with histologically confirmed lung cancer (irrespective of histology) and an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0 (asymptomatic) to 2 (symptomatic but out of bed for &gt;50% of the day)).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="178"/>
                <count group_id="O2" value="348"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="99"/>
                    <measurement group_id="O2" value="132"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="79"/>
                    <measurement group_id="O2" value="216"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.25</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.50</ci_lower_limit>
            <ci_upper_limit>3.36</ci_upper_limit>
            <estimate_desc>Odds ratio comparing Multidisciplinary Clinic patients with and without tri-modal staging (numerator=99/79) to Serial Care patients with and without tri-modal staging (denominator=132/216) after adjustment for matched study design.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Thoroughness of Invasive Staging, MD vs SC (Conference) vs SC (no Conference)</title>
        <description>Number of patients with a test that provides tissue confirmation of the stage-defining lesion. Tests include a biopsy of any identified suspicious metastatic lesion or the primary lesion in the absence of any other suspicious lesion.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
        <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
        <population>All Specific Aim 3 patients (patients with histologically confirmed lung cancer (irrespective of histology) and an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0 (asymptomatic) to 2 (symptomatic but out of bed for &gt;50% of the day)).</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients Presented in Conference</title>
            <description>Serial care patients who were presented in the multidisciplinary conference but not seen in the multidisciplinary clinic.</description>
          </group>
          <group group_id="O3">
            <title>Serial Care Patients Not Presented in Conference</title>
            <description>Serial care patients who were not presented in the multidisciplinary conference.</description>
          </group>
        </group_list>
        <measure>
          <title>Thoroughness of Invasive Staging, MD vs SC (Conference) vs SC (no Conference)</title>
          <description>Number of patients with a test that provides tissue confirmation of the stage-defining lesion. Tests include a biopsy of any identified suspicious metastatic lesion or the primary lesion in the absence of any other suspicious lesion.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
          <population>All Specific Aim 3 patients (patients with histologically confirmed lung cancer (irrespective of histology) and an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0 (asymptomatic) to 2 (symptomatic but out of bed for &gt;50% of the day)).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="178"/>
                <count group_id="O2" value="76"/>
                <count group_id="O3" value="272"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="108"/>
                    <measurement group_id="O2" value="46"/>
                    <measurement group_id="O3" value="122"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="70"/>
                    <measurement group_id="O2" value="30"/>
                    <measurement group_id="O3" value="150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0366</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.580</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.665</ci_lower_limit>
            <ci_upper_limit>3.996</ci_upper_limit>
            <estimate_desc>Odds ratio comparing Multidisciplinary Clinic patients with and without invasive staging (numerator=108/70) to Serial Care patients not in conference with and without invasive staging (denominator=122/150) after adjustment for matched study design.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0779</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.621</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.473</ci_lower_limit>
            <ci_upper_limit>4.665</ci_upper_limit>
            <estimate_desc>Odds ratio comparing Serial Care patients in conference with and without invasive staging (numerator=46/30) to Serial Care patients not in conference with and without invasive staging (denominator=122/150) after adjustment for matched study design.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Thoroughness of Invasive Mediastinal Staging, MD vs SC (no Conference) vs SC (Conference)</title>
        <description>Number of patients with a test (i.e., biopsy) that provides tissue confirmation of the presence or absence mediastinal nodal metastasis.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
        <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
        <population>All Specific Aim 3 patients (patients with histologically confirmed lung cancer (irrespective of histology) and an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0 (asymptomatic) to 2 (symptomatic but out of bed for &gt;50% of the day)).</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients Presented in Conference</title>
            <description>Serial care patients who were presented in the multidisciplinary conference but not seen in the multidisciplinary clinic.</description>
          </group>
          <group group_id="O3">
            <title>Serial Care Patients Not Presented in Conference</title>
            <description>Serial care patients who were not presented in the multidisciplinary conference.</description>
          </group>
        </group_list>
        <measure>
          <title>Thoroughness of Invasive Mediastinal Staging, MD vs SC (no Conference) vs SC (Conference)</title>
          <description>Number of patients with a test (i.e., biopsy) that provides tissue confirmation of the presence or absence mediastinal nodal metastasis.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
          <population>All Specific Aim 3 patients (patients with histologically confirmed lung cancer (irrespective of histology) and an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0 (asymptomatic) to 2 (symptomatic but out of bed for &gt;50% of the day)).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="178"/>
                <count group_id="O2" value="76"/>
                <count group_id="O3" value="272"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="91"/>
                    <measurement group_id="O2" value="40"/>
                    <measurement group_id="O3" value="86"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="87"/>
                    <measurement group_id="O2" value="36"/>
                    <measurement group_id="O3" value="186"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0703</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.358</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.536</ci_lower_limit>
            <ci_upper_limit>3.621</ci_upper_limit>
            <estimate_desc>Odds ratio comparing Multidisciplinary Clinic patients with and without mediastinal staging (numerator=91/87) to Serial Care patients not in conference with and without mediastinal staging (denominator=86/186) after adjustment for matched study.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0631</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.535</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.446</ci_lower_limit>
            <ci_upper_limit>4.444</ci_upper_limit>
            <estimate_desc>Odds ratio comparing Serial Care patients in conference with and without mediastinal staging (numerator=40/36) to Serial Care patients not in conference with and without mediastinal staging (denominator=86/186) after adjustment for matched study.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Thoroughness of Bi-Modal Staging Practice, MD vs SC (Conference) vs SC (no Conference)</title>
        <description>Number of patients receiving two forms of staging tests (bi-modal staging). Bi-modal staging is defined as a CT scan plus any other type of radiologic scan or any biopsy.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
        <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
        <population>All Specific Aim 3 patients (patients with histologically confirmed lung cancer (irrespective of histology) and an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0 (asymptomatic) to 2 (symptomatic but out of bed for &gt;50% of the day)).</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients Presented in Conference</title>
            <description>Serial care patients who were presented in the multidisciplinary conference but not seen in the multidisciplinary clinic.</description>
          </group>
          <group group_id="O3">
            <title>Serial Care Patients Not Presented in Conference</title>
            <description>Serial care patients who were not presented in the multidisciplinary conference.</description>
          </group>
        </group_list>
        <measure>
          <title>Thoroughness of Bi-Modal Staging Practice, MD vs SC (Conference) vs SC (no Conference)</title>
          <description>Number of patients receiving two forms of staging tests (bi-modal staging). Bi-modal staging is defined as a CT scan plus any other type of radiologic scan or any biopsy.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
          <population>All Specific Aim 3 patients (patients with histologically confirmed lung cancer (irrespective of histology) and an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0 (asymptomatic) to 2 (symptomatic but out of bed for &gt;50% of the day)).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="178"/>
                <count group_id="O2" value="76"/>
                <count group_id="O3" value="272"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="161"/>
                    <measurement group_id="O2" value="62"/>
                    <measurement group_id="O3" value="205"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0010</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>3.191</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.671</ci_lower_limit>
            <ci_upper_limit>6.093</ci_upper_limit>
            <estimate_desc>Odds ratio comparing Multidisciplinary Clinic patients with and without bi-modal staging (numerator=161/17) to Serial Care patients not in conference with and without bi-modal staging (denominator=205/67) after adjustment for matched study.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.1972</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.103</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.526</ci_lower_limit>
            <ci_upper_limit>2.314</ci_upper_limit>
            <estimate_desc>Odds ratio comparing Serial Care patients in conference with and without bi-modal staging (numerator=62/14) to Serial Care patients not in conference with and without bi-modal staging (denominator=205/67) after adjustment for matched study.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Thoroughness of Tri-Modal Staging Practice, MD vs SC (Conference) vs SC (no Conference)</title>
        <description>Number of patients receiving three forms of staging tests (tri-modal staging). Tri-modal staging is defined as a CT scan plus any other type of radiologic scan plus any biopsy, or PET/CT plus any biopsy.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
        <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
        <population>All Specific Aim 3 patients (patients with histologically confirmed lung cancer (irrespective of histology) and an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0 (asymptomatic) to 2 (symptomatic but out of bed for &gt;50% of the day)).</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients Presented in Conference</title>
            <description>Serial care patients who were presented in the multidisciplinary conference but not seen in the multidisciplinary clinic.</description>
          </group>
          <group group_id="O3">
            <title>Serial Care Patients Not Presented in Conference</title>
            <description>Serial care patients who were not presented in the multidisciplinary conference.</description>
          </group>
        </group_list>
        <measure>
          <title>Thoroughness of Tri-Modal Staging Practice, MD vs SC (Conference) vs SC (no Conference)</title>
          <description>Number of patients receiving three forms of staging tests (tri-modal staging). Tri-modal staging is defined as a CT scan plus any other type of radiologic scan plus any biopsy, or PET/CT plus any biopsy.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
          <population>All Specific Aim 3 patients (patients with histologically confirmed lung cancer (irrespective of histology) and an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0 (asymptomatic) to 2 (symptomatic but out of bed for &gt;50% of the day)).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="178"/>
                <count group_id="O2" value="76"/>
                <count group_id="O3" value="272"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="99"/>
                    <measurement group_id="O2" value="39"/>
                    <measurement group_id="O3" value="93"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="79"/>
                    <measurement group_id="O2" value="37"/>
                    <measurement group_id="O3" value="179"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0055</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.739</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.785</ci_lower_limit>
            <ci_upper_limit>4.203</ci_upper_limit>
            <estimate_desc>Odds ratio comparing Multidisciplinary Clinic patients with and without tri-modal staging (numerator=99/79) to Serial Care patients not in conference with and without tri-modal staging (denominator=93/179) after adjustment for matched study.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2572</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.242</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.287</ci_lower_limit>
            <ci_upper_limit>3.905</ci_upper_limit>
            <estimate_desc>Odds ratio comparing Serial Care patients in conference with and without tri-modal staging (numerator=39/37) to Serial Care patients not in conference with and without tri-modal staging (denominator=93/179) after adjustment for matched study.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Stage-Appropriateness Treatment Selection, MD vs SC</title>
        <description>Number of patients for whom appropriate treatment was given, as determined by the patients' clinical stage and treatment guidelines stipulated by the National Comprehensive Cancer Network (NCCN). 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.
For Stage I or II: surgery (or radiation therapy with documented contraindication to surgery or patient refusal); for Stage III: chemotherapy and radiation therapy with or without surgery; for Stage IV: systemic therapy (or palliative care with documented patient refusal or contraindication to systemic therapy).</description>
        <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
        <population>Patients with a conference lung cancer who enrolled in the study who did not die, or leave the study before treatment, or did not refuse treatment.</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients</title>
            <description>Patients seen and treated in the standard, sequential-referral-based environment of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Stage-Appropriateness Treatment Selection, MD vs SC</title>
          <description>Number of patients for whom appropriate treatment was given, as determined by the patients' clinical stage and treatment guidelines stipulated by the National Comprehensive Cancer Network (NCCN). 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.
For Stage I or II: surgery (or radiation therapy with documented contraindication to surgery or patient refusal); for Stage III: chemotherapy and radiation therapy with or without surgery; for Stage IV: systemic therapy (or palliative care with documented patient refusal or contraindication to systemic therapy).</description>
          <population>Patients with a conference lung cancer who enrolled in the study who did not die, or leave the study before treatment, or did not refuse treatment.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="173"/>
                <count group_id="O2" value="338"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="140"/>
                    <measurement group_id="O2" value="232"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0045</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.01</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.24</ci_lower_limit>
            <ci_upper_limit>3.25</ci_upper_limit>
            <estimate_desc>Odds ratio comparing MD patients with and without stage appropriate treatment (numerator=140/33) to SC patients with and without stage appropriate treatment (denominator=232/106) after adjustment for matched study.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Stage-Appropriateness Treatment Selection, MD vs SC (Conference) vs SC (no Conference)</title>
        <description>Number of patients for whom appropriate treatment was given, as determined by the patients' clinical stage and treatment guidelines stipulated by the National Comprehensive Cancer Network (NCCN).
For Stage I or II: surgery (or radiation therapy with documented contraindication to surgery or patient refusal); for Stage III: chemotherapy and radiation therapy with or without surgery; for Stage IV: systemic therapy (or palliative care with documented patient refusal or contraindication to systemic therapy).
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
        <time_frame>From the time of a patient's positive lung cancer diagnosis, to the start of a patient's first-line of treatment, an average of 1-2 months</time_frame>
        <population>Patients with a conference lung cancer who enrolled in the study who did not die, or leave the study before treatment, or did not refuse treatment.</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients Presented in Conference</title>
            <description>Serial care patients who were presented in the multidisciplinary conference but not seen in the multidisciplinary clinic.</description>
          </group>
          <group group_id="O3">
            <title>Serial Care Patients Not Presented in Conference</title>
            <description>Serial care patients who were not presented in the multidisciplinary conference.</description>
          </group>
        </group_list>
        <measure>
          <title>Stage-Appropriateness Treatment Selection, MD vs SC (Conference) vs SC (no Conference)</title>
          <description>Number of patients for whom appropriate treatment was given, as determined by the patients' clinical stage and treatment guidelines stipulated by the National Comprehensive Cancer Network (NCCN).
For Stage I or II: surgery (or radiation therapy with documented contraindication to surgery or patient refusal); for Stage III: chemotherapy and radiation therapy with or without surgery; for Stage IV: systemic therapy (or palliative care with documented patient refusal or contraindication to systemic therapy).
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
          <population>Patients with a conference lung cancer who enrolled in the study who did not die, or leave the study before treatment, or did not refuse treatment.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="173"/>
                <count group_id="O2" value="73"/>
                <count group_id="O3" value="265"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="140"/>
                    <measurement group_id="O2" value="58"/>
                    <measurement group_id="O3" value="174"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>We examined treatment selection practices with or without MD care in a single healthcare system.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0474</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.249</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.368</ci_lower_limit>
            <ci_upper_limit>3.699</ci_upper_limit>
            <estimate_desc>Odds ratio comparing MD patients with and without stage appropriate treatment (numerator=140/33) to SC patients not in conference with and without stage appropriate treatment (denominator=174/91) after adjustment for matched study.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6353</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.751</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.910</ci_lower_limit>
            <ci_upper_limit>3.370</ci_upper_limit>
            <estimate_desc>Odds ratio comparing SC patients in conference with and without stage appropriate treatment (numerator=58/15) to SC patients not in conference with and without stage appropriate treatment (denominator=174/91) after adjustment for matched study.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Timeliness of Communication, MD vs SC(Conference)</title>
        <description>Number of patients for whom formal, verified communication of care management decisions was made to all team members (providers inside and outside the multidisciplinary program, patients and their care-givers) within 48 hours of a care recommendation being made. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
        <time_frame>Within 48 hours of a documented care recommendation made through the multidisciplinary thoracic oncology program</time_frame>
        <population>Patients with a conference lung cancer who enrolled in the study who did not die, or leave the study before treatment, or did not refuse treatment.</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients Presented in Conference</title>
            <description>Serial care patients who were presented in the multidisciplinary conference but not seen in the multidisciplinary clinic.</description>
          </group>
          <group group_id="O3">
            <title>Overall Conference</title>
            <description>All Patients presented in conference</description>
          </group>
        </group_list>
        <measure>
          <title>Timeliness of Communication, MD vs SC(Conference)</title>
          <description>Number of patients for whom formal, verified communication of care management decisions was made to all team members (providers inside and outside the multidisciplinary program, patients and their care-givers) within 48 hours of a care recommendation being made. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
          <population>Patients with a conference lung cancer who enrolled in the study who did not die, or leave the study before treatment, or did not refuse treatment.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="178"/>
                <count group_id="O2" value="76"/>
                <count group_id="O3" value="254"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="168"/>
                    <measurement group_id="O2" value="74"/>
                    <measurement group_id="O3" value="242"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Concordance Rate for Initial Conference Recommendations, MD vs SC (Conference)</title>
        <description>Number of patients for whom all recommendations made at the initial multidisciplinary conference were completed. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients. Note that two patients (one from the MD arm and one from the SC arm) have died before receiving recommendations and therefore were not analyzed for this outcome.</description>
        <time_frame>From the time of a patient's positive lung cancer diagnosis, to the end of a patient's last line of treatment, an average of 1-2 months</time_frame>
        <population>Patients with a conference lung cancer who enrolled in the study who did not die, or leave the study before treatment, or did not refuse treatment.</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Conference Patients</title>
            <description>Serial care patients who were presented in the multidisciplinary conference but not seen in the multidisciplinary clinic.</description>
          </group>
        </group_list>
        <measure>
          <title>Concordance Rate for Initial Conference Recommendations, MD vs SC (Conference)</title>
          <description>Number of patients for whom all recommendations made at the initial multidisciplinary conference were completed. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients. Note that two patients (one from the MD arm and one from the SC arm) have died before receiving recommendations and therefore were not analyzed for this outcome.</description>
          <population>Patients with a conference lung cancer who enrolled in the study who did not die, or leave the study before treatment, or did not refuse treatment.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="177"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="140"/>
                    <measurement group_id="O2" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0014</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.955</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.520</ci_lower_limit>
            <ci_upper_limit>5.747</ci_upper_limit>
            <estimate_desc>Odds ratio comparing MD patients with and without concordance to recommendations (numerator=140/37) to SC conference patients with and without concordance to recommendations (denominator=45/30) after adjustment for matched study design.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Concordance Rate for Initial Conference Recommendation(s) With Prior Condition Met, MD vs SC (Conference)</title>
        <description>Number of patients for whom all initial conference recommendations were completed, excluding conditional recommendations for which the prior condition was not met. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients. Note that two patients (one from the MD arm and one from the SC arm) have died before receiving recommendations and therefore were not analyzed for this outcome.
E.g., if a recommendation was to have a PET/CT and then a staging biopsy if the PET showed suspicious metastatic disease, the staging biopsy recommendation was excluded from the concordance measure if the PET/CT did not happen or was negative.</description>
        <time_frame>From the time of a patient's positive lung cancer diagnosis, to the end of a patient's last line of treatment, an average of 1-2 months</time_frame>
        <population>Patients with a conference lung cancer who enrolled in the study who did not die, or leave the study before treatment, or did not refuse treatment.</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Conference Patients</title>
            <description>Serial care patients who were presented in the multidisciplinary conference but not seen in the multidisciplinary clinic.</description>
          </group>
        </group_list>
        <measure>
          <title>Concordance Rate for Initial Conference Recommendation(s) With Prior Condition Met, MD vs SC (Conference)</title>
          <description>Number of patients for whom all initial conference recommendations were completed, excluding conditional recommendations for which the prior condition was not met. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients. Note that two patients (one from the MD arm and one from the SC arm) have died before receiving recommendations and therefore were not analyzed for this outcome.
E.g., if a recommendation was to have a PET/CT and then a staging biopsy if the PET showed suspicious metastatic disease, the staging biopsy recommendation was excluded from the concordance measure if the PET/CT did not happen or was negative.</description>
          <population>Patients with a conference lung cancer who enrolled in the study who did not die, or leave the study before treatment, or did not refuse treatment.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="177"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="145"/>
                    <measurement group_id="O2" value="49"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0019</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>3.093</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.519</ci_lower_limit>
            <ci_upper_limit>6.299</ci_upper_limit>
            <estimate_desc>Odds ratio comparing MD patients with and without concordance to recommendations (numerator=145/32) to SC conference patients with and without concordance to recommendations (denominator=49/26) after adjustment for matched study design.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Concordance Rate for Any Conference Recommendation, MD vs SC (Conference)</title>
        <description>Number of patients for whom any initial conference recommendation was completed. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients. Note that two patients (one from the MD arm and one from the SC arm) have died before receiving recommendations and therefore were not analyzed for this outcome.</description>
        <time_frame>From the time of a patient's positive lung cancer diagnosis, to the end of a patient's last line of treatment, an average of 1-2 months</time_frame>
        <population>Patients with a conference lung cancer who enrolled in the study who did not die, or leave the study before treatment, or did not refuse treatment.</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Conference Patients</title>
            <description>Serial care patients who were presented in the multidisciplinary conference but not seen in the multidisciplinary clinic.</description>
          </group>
        </group_list>
        <measure>
          <title>Concordance Rate for Any Conference Recommendation, MD vs SC (Conference)</title>
          <description>Number of patients for whom any initial conference recommendation was completed. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients. Note that two patients (one from the MD arm and one from the SC arm) have died before receiving recommendations and therefore were not analyzed for this outcome.</description>
          <population>Patients with a conference lung cancer who enrolled in the study who did not die, or leave the study before treatment, or did not refuse treatment.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="177"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="174"/>
                    <measurement group_id="O2" value="71"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0499</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>40.892</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.002</ci_lower_limit>
            <ci_upper_limit>999.999</ci_upper_limit>
            <estimate_desc>Odds ratio comparing MD patients with and without concordance to recommendations (numerator=174/3) to SC conference patients with and without concordance to recommendations (denominator=71/4) after adjustment for matched study design.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Overall Concordance Rate Using a Hierarchy of Initial Conference Recommendations, MD vs SC (Conference)</title>
        <description>Number of patients for whom the overall initial conference recommendation was completed. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients. Note that two patients (one from the MD arm and one from the SC arm) have died before receiving recommendations and therefore were not analyzed for this outcome.
The hierarchy to rank recommendations, from highest priority to lowest, was (1) treatment, (2) staging, (3) diagnosis, (4) surveillance.
If a patient had a treatment recommendation and it happened, he/she was concordant. If treatment was recommended and it did not happen, he/she was discordant. If no treatment recommendation was made, then concordance was measured by whether or not the staging recommendation was met. If no staging recommendation was made, then the diagnostic recommendation was given priority for a concordance measurement. If no diagnostic recommendation, then a surveillance recommendation was used to measure overall concordance.</description>
        <time_frame>From the time of a patient's positive lung cancer diagnosis, to the end of a patient's last line of treatment, an average of 1-2 months</time_frame>
        <population>Patients with a conference lung cancer who enrolled in the study who did not die, or leave the study before treatment, or did not refuse treatment.</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Conference Patients</title>
            <description>Serial care patients who were presented in the multidisciplinary conference but not seen in the multidisciplinary clinic.</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Concordance Rate Using a Hierarchy of Initial Conference Recommendations, MD vs SC (Conference)</title>
          <description>Number of patients for whom the overall initial conference recommendation was completed. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients. Note that two patients (one from the MD arm and one from the SC arm) have died before receiving recommendations and therefore were not analyzed for this outcome.
The hierarchy to rank recommendations, from highest priority to lowest, was (1) treatment, (2) staging, (3) diagnosis, (4) surveillance.
If a patient had a treatment recommendation and it happened, he/she was concordant. If treatment was recommended and it did not happen, he/she was discordant. If no treatment recommendation was made, then concordance was measured by whether or not the staging recommendation was met. If no staging recommendation was made, then the diagnostic recommendation was given priority for a concordance measurement. If no diagnostic recommendation, then a surveillance recommendation was used to measure overall concordance.</description>
          <population>Patients with a conference lung cancer who enrolled in the study who did not die, or leave the study before treatment, or did not refuse treatment.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="177"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="158"/>
                    <measurement group_id="O2" value="60"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0263</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.663</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.123</ci_lower_limit>
            <ci_upper_limit>6.319</ci_upper_limit>
            <estimate_desc>Odds ratio comparing MD patients with and without concordance to recommendations (numerator=158/19) to SC conference patients with and without concordance to recommendations (denominator=60/15) after adjustment for matched study design.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Concordance Rate for Treatment Recommendations With Prior Recommendations Completed, MD vs SC (Conference)</title>
        <description>Number of patients for whom the treatment recommendation made at the initial conference presentation was completed, excluding any patient for whom prior recommendations (staging, diagnosis, surveillance) were not also completed. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
        <time_frame>From the time of a patient's positive lung cancer diagnosis, to the end of a patient's last line of treatment, an average of 1-2 months</time_frame>
        <population>Patients with a conference lung cancer who enrolled in the study who did not die, or leave the study before treatment, or did not refuse treatment excluding any patient for whom prior recommendations (staging, diagnosis, surveillance) were not also completed.</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Conference Patients</title>
            <description>Serial care patients who were presented in the multidisciplinary conference but not seen in the multidisciplinary clinic.</description>
          </group>
        </group_list>
        <measure>
          <title>Concordance Rate for Treatment Recommendations With Prior Recommendations Completed, MD vs SC (Conference)</title>
          <description>Number of patients for whom the treatment recommendation made at the initial conference presentation was completed, excluding any patient for whom prior recommendations (staging, diagnosis, surveillance) were not also completed. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
          <population>Patients with a conference lung cancer who enrolled in the study who did not die, or leave the study before treatment, or did not refuse treatment excluding any patient for whom prior recommendations (staging, diagnosis, surveillance) were not also completed.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="101"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="87"/>
                    <measurement group_id="O2" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.1503</p_value>
            <p_value_desc>Conditional logistic regression adjusted for the matched study design, sex, age, and histology.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.566</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.711</ci_lower_limit>
            <ci_upper_limit>9.269</ci_upper_limit>
            <estimate_desc>Odds ratio comparing MD patients with and without concordance to recommendations (numerator=87/14) to SC conference patients with and without concordance to recommendations (denominator=38/8) after adjustment for matched study design.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Baseline Patient Survey Response Rate, MD vs SC</title>
        <description>Number of patients who completed a baseline patient survey</description>
        <time_frame>Baseline</time_frame>
        <population>Patients who were offered baseline surveys (all Specific Aim 3 patients)</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients</title>
            <description>Patients seen and treated in the standard, sequential-referral-based environment of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Patient Survey Response Rate, MD vs SC</title>
          <description>Number of patients who completed a baseline patient survey</description>
          <population>Patients who were offered baseline surveys (all Specific Aim 3 patients)</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="178"/>
                <count group_id="O2" value="348"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="156"/>
                    <measurement group_id="O2" value="306"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>3-month Patient Survey Response Rate, MD vs SC</title>
        <description>Number of patients who completed a 3-month survey</description>
        <time_frame>Within 30 days of 3 months after baseline survey administration</time_frame>
        <population>Patients who were offered 3-month surveys.</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients</title>
            <description>Patients seen and treated in the standard, sequential-referral-based environment of care.</description>
          </group>
        </group_list>
        <measure>
          <title>3-month Patient Survey Response Rate, MD vs SC</title>
          <description>Number of patients who completed a 3-month survey</description>
          <population>Patients who were offered 3-month surveys.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
                <count group_id="O2" value="306"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="99"/>
                    <measurement group_id="O2" value="189"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="57"/>
                    <measurement group_id="O2" value="117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>6-Month Patient Survey Response Rate, MD vs SC</title>
        <description>Number of patients who completed a 6-month survey</description>
        <time_frame>Within 30 days of 6 months after baseline survey administration</time_frame>
        <population>Patients who were offered 6-month surveys. Note that patients were offered a 6-month survey even if they did not complete a 3-month survey.</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients</title>
            <description>Patients seen and treated in the standard, sequential-referral-based environment of care.</description>
          </group>
        </group_list>
        <measure>
          <title>6-Month Patient Survey Response Rate, MD vs SC</title>
          <description>Number of patients who completed a 6-month survey</description>
          <population>Patients who were offered 6-month surveys. Note that patients were offered a 6-month survey even if they did not complete a 3-month survey.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
                <count group_id="O2" value="306"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="101"/>
                    <measurement group_id="O2" value="178"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                    <measurement group_id="O2" value="128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Patient Survey Scores at Baseline, MD vs SC</title>
        <description>Scores from patient surveys that measure quality of life and satisfaction with care received at the time the baseline survey was taken.
Overall quality of health care - satisfaction with overall quality of health care since lung cancer diagnosis; range: 0-4 (higher is better) Financial burden of care - assessment of financial burden of care; range: 3-6 (sum of 3 items, higher is worse) Treatment decision-making: Surgery/Radiation/Chemotherapy - each 1 item; satisfaction with treatment decision-making; range: 0-2 (0=patient controlled; 1=shared decision; 2-physician decision; closer to 1 is best) Satisfaction with treatment plan - satisfaction with overall treatment plan; range: 1-5 (sum of 2 items, higher is better) Treatment decision-making: family role - satisfaction with family role in treatment decision-making; range: 0-2 (0=patient controlled; 1=shared decision; 2-physician decision; closer to 1 is best) (descriptions continued in 3 month survey description)</description>
        <time_frame>Baseline</time_frame>
        <population>Patients who completed baseline surveys.</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients</title>
            <description>Patients seen and treated in the standard, sequential-referral-based environment of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Survey Scores at Baseline, MD vs SC</title>
          <description>Scores from patient surveys that measure quality of life and satisfaction with care received at the time the baseline survey was taken.
Overall quality of health care - satisfaction with overall quality of health care since lung cancer diagnosis; range: 0-4 (higher is better) Financial burden of care - assessment of financial burden of care; range: 3-6 (sum of 3 items, higher is worse) Treatment decision-making: Surgery/Radiation/Chemotherapy - each 1 item; satisfaction with treatment decision-making; range: 0-2 (0=patient controlled; 1=shared decision; 2-physician decision; closer to 1 is best) Satisfaction with treatment plan - satisfaction with overall treatment plan; range: 1-5 (sum of 2 items, higher is better) Treatment decision-making: family role - satisfaction with family role in treatment decision-making; range: 0-2 (0=patient controlled; 1=shared decision; 2-physician decision; closer to 1 is best) (descriptions continued in 3 month survey description)</description>
          <population>Patients who completed baseline surveys.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
                <count group_id="O2" value="306"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Overall quality of health care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.28" spread="0.99"/>
                    <measurement group_id="O2" value="3.15" spread="0.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Financial burden of care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.32" spread="1.07"/>
                    <measurement group_id="O2" value="5.23" spread="1.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.92" spread="0.60"/>
                    <measurement group_id="O2" value="1.14" spread="0.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Radiation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.97" spread="0.64"/>
                    <measurement group_id="O2" value="1.10" spread="0.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Chemotherapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.03" spread="0.66"/>
                    <measurement group_id="O2" value="1.01" spread="0.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with treatment plan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.95" spread="1.54"/>
                    <measurement group_id="O2" value="4.31" spread="1.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Family role</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.73" spread="0.56"/>
                    <measurement group_id="O2" value="0.69" spread="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with quality of care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.05" spread="2.56"/>
                    <measurement group_id="O2" value="13.58" spread="3.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with physician communication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.42" spread="2.86"/>
                    <measurement group_id="O2" value="18.49" spread="2.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with nurse communication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.55" spread="2.75"/>
                    <measurement group_id="O2" value="16.71" spread="2.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall team satisfaction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.69" spread="3.41"/>
                    <measurement group_id="O2" value="12.24" spread="3.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical well-being</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.90" spread="7.61"/>
                    <measurement group_id="O2" value="24.88" spread="6.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social well-being</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.73" spread="5.23"/>
                    <measurement group_id="O2" value="18.32" spread="3.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Functional well-being</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.14" spread="7.33"/>
                    <measurement group_id="O2" value="22.05" spread="7.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emotional well-being</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.23" spread="6.04"/>
                    <measurement group_id="O2" value="24.04" spread="6.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lung cancer specific QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.87" spread="5.52"/>
                    <measurement group_id="O2" value="32.25" spread="5.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total Summary Score FACTL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="121.00" spread="21.42"/>
                    <measurement group_id="O2" value="121.71" spread="21.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Generic score FACTG</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.16" spread="18.17"/>
                    <measurement group_id="O2" value="89.40" spread="17.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Trial outcome index</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.70" spread="16.19"/>
                    <measurement group_id="O2" value="79.17" spread="15.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Depression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.44" spread="3.91"/>
                    <measurement group_id="O2" value="4.92" spread="4.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anxiety</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.53" spread="4.08"/>
                    <measurement group_id="O2" value="5.03" spread="4.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Patient Survey Scores at 3 Months, MD vs SC</title>
        <description>Scores from patient surveys that measure quality of life and satisfaction with care received at the time the 3-month survey was taken.
(continued from baseline) Satisfaction with quality of care - overall satisfaction with care received from all care team members; range: 0-18 (sum of 6 items, higher is better) Satisfaction with physician communication - overall satisfaction with physician communication; range: 0-21 (sum of 7 items, higher is better) Satisfaction with nurse communication - overall satisfaction with nurse communication; range: 0-18 (sum of 6 items, higher is better) Overall team satisfaction - CAHPS satisfaction with care from team as a whole; range: 0-15 (sum of 4 items, higher is better) Physical/Social/Functional well-being - health-related quality of life relating to physical/social/functional well-being; range 0-28 (each a sum of 7 items, higher is better) (description continues in 6 month survey description)</description>
        <time_frame>Within 30 days of 3 months after baseline survey administration</time_frame>
        <population>Patients who completed 3-month surveys.</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients</title>
            <description>Patients seen and treated in the standard, sequential-referral-based environment of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Survey Scores at 3 Months, MD vs SC</title>
          <description>Scores from patient surveys that measure quality of life and satisfaction with care received at the time the 3-month survey was taken.
(continued from baseline) Satisfaction with quality of care - overall satisfaction with care received from all care team members; range: 0-18 (sum of 6 items, higher is better) Satisfaction with physician communication - overall satisfaction with physician communication; range: 0-21 (sum of 7 items, higher is better) Satisfaction with nurse communication - overall satisfaction with nurse communication; range: 0-18 (sum of 6 items, higher is better) Overall team satisfaction - CAHPS satisfaction with care from team as a whole; range: 0-15 (sum of 4 items, higher is better) Physical/Social/Functional well-being - health-related quality of life relating to physical/social/functional well-being; range 0-28 (each a sum of 7 items, higher is better) (description continues in 6 month survey description)</description>
          <population>Patients who completed 3-month surveys.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="99"/>
                <count group_id="O2" value="189"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Overall quality of health care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.31" spread="0.89"/>
                    <measurement group_id="O2" value="3.30" spread="0.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Financial burden of care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.25" spread="1.16"/>
                    <measurement group_id="O2" value="5.11" spread="1.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.93" spread="0.61"/>
                    <measurement group_id="O2" value="1.17" spread="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Radiation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.07" spread="0.55"/>
                    <measurement group_id="O2" value="1.13" spread="0.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Chemotherapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.97" spread="0.58"/>
                    <measurement group_id="O2" value="1.05" spread="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with treatment plan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.60" spread="0.82"/>
                    <measurement group_id="O2" value="4.59" spread="0.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Family role</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.72" spread="0.50"/>
                    <measurement group_id="O2" value="0.74" spread="0.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with quality of care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.09" spread="2.36"/>
                    <measurement group_id="O2" value="14.33" spread="2.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with physician communication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.03" spread="2.34"/>
                    <measurement group_id="O2" value="19.01" spread="2.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with nurse communication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.17" spread="2.54"/>
                    <measurement group_id="O2" value="17.33" spread="1.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall team satisfaction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.94" spread="2.04"/>
                    <measurement group_id="O2" value="13.69" spread="2.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical well-being</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.62" spread="7.00"/>
                    <measurement group_id="O2" value="26.25" spread="7.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social well-being</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.42" spread="3.85"/>
                    <measurement group_id="O2" value="18.92" spread="3.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Functional well-being</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.57" spread="7.17"/>
                    <measurement group_id="O2" value="23.16" spread="6.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emotional well-being</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.69" spread="5.50"/>
                    <measurement group_id="O2" value="24.85" spread="5.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lung cancer specific QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.31" spread="5.89"/>
                    <measurement group_id="O2" value="33.36" spread="5.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total Summary Score FACTL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="124.89" spread="22.12"/>
                    <measurement group_id="O2" value="126.59" spread="19.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Generic score FACTG</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.67" spread="18.33"/>
                    <measurement group_id="O2" value="93.16" spread="16.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Trial outcome index</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.39" spread="17.03"/>
                    <measurement group_id="O2" value="82.77" spread="15.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Depression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.37" spread="4.15"/>
                    <measurement group_id="O2" value="4.81" spread="3.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anxiety</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.79" spread="4.02"/>
                    <measurement group_id="O2" value="4.50" spread="4.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Patient Survey Scores at 6 Months, MD vs SC</title>
        <description>Scores from patient surveys that measure quality of life and satisfaction with care received at the time the 6-month survey was taken.
(cont) Emotional well-being - health-related quality of life related to emotional well-being; range 0-30 (sum of 6 items, higher is better) Lung cancer specific QOL - health-related quality of life related to lung cancer diagnosis; range: 0-36 (sum of 9 items, higher is better) Total Summary Score FACTL - full survey, functional assessment of cancer therapy - lung; range: 0-136 (sum of 36 items, higher is better) Generic Score FACTG - full survey, functional assessment of cancer therapy - general; range: 0-108 (sum of 27 items, higher is better) Trial Outcome Index - health related quality of life - trial outcome index; range: 0-84 (sum of 23 items, higher is better) Depression/Anxiety - depression/anxiety measured by Hospital Anxiety and Depression Scale; range: 0-21 (sum of 7 items each, higher is worse)</description>
        <time_frame>Within 30 days of 6 months after baseline survey administration</time_frame>
        <population>Patients who completed 6-month surveys.</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients</title>
            <description>Patients seen and treated in the standard, sequential-referral-based environment of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Survey Scores at 6 Months, MD vs SC</title>
          <description>Scores from patient surveys that measure quality of life and satisfaction with care received at the time the 6-month survey was taken.
(cont) Emotional well-being - health-related quality of life related to emotional well-being; range 0-30 (sum of 6 items, higher is better) Lung cancer specific QOL - health-related quality of life related to lung cancer diagnosis; range: 0-36 (sum of 9 items, higher is better) Total Summary Score FACTL - full survey, functional assessment of cancer therapy - lung; range: 0-136 (sum of 36 items, higher is better) Generic Score FACTG - full survey, functional assessment of cancer therapy - general; range: 0-108 (sum of 27 items, higher is better) Trial Outcome Index - health related quality of life - trial outcome index; range: 0-84 (sum of 23 items, higher is better) Depression/Anxiety - depression/anxiety measured by Hospital Anxiety and Depression Scale; range: 0-21 (sum of 7 items each, higher is worse)</description>
          <population>Patients who completed 6-month surveys.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="101"/>
                <count group_id="O2" value="178"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Overall quality of health care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.36" spread="0.74"/>
                    <measurement group_id="O2" value="3.15" spread="0.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Financial burden of care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.48" spread="0.99"/>
                    <measurement group_id="O2" value="5.06" spread="1.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.15" spread="0.55"/>
                    <measurement group_id="O2" value="1.09" spread="0.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Radiation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.09" spread="0.62"/>
                    <measurement group_id="O2" value="1.05" spread="0.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with treatment plan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.89" spread="0.46"/>
                    <measurement group_id="O2" value="4.58" spread="0.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Chemo</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.15" spread="0.55"/>
                    <measurement group_id="O2" value="1.06" spread="0.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Family role</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.83" spread="0.42"/>
                    <measurement group_id="O2" value="0.75" spread="0.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with quality of care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.89" spread="2.21"/>
                    <measurement group_id="O2" value="14.41" spread="2.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with physician communication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.33" spread="1.50"/>
                    <measurement group_id="O2" value="19.08" spread="1.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with nurse communication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.32" spread="1.88"/>
                    <measurement group_id="O2" value="17.04" spread="2.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall team satisfaction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.19" spread="1.59"/>
                    <measurement group_id="O2" value="13.73" spread="2.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical well-being</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.46" spread="5.59"/>
                    <measurement group_id="O2" value="26.94" spread="6.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social well-being</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.62" spread="3.78"/>
                    <measurement group_id="O2" value="18.29" spread="3.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Functional well-being</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.22" spread="6.07"/>
                    <measurement group_id="O2" value="23.41" spread="6.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emotional well-being</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.15" spread="4.63"/>
                    <measurement group_id="O2" value="25.26" spread="4.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lung cancer specific QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.49" spread="5.96"/>
                    <measurement group_id="O2" value="33.59" spread="5.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total Summary Score FACTL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="132.00" spread="18.26"/>
                    <measurement group_id="O2" value="128.00" spread="19.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Generic score FACTG</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.61" spread="14.19"/>
                    <measurement group_id="O2" value="94.26" spread="15.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Trial outcome index</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.92" spread="14.39"/>
                    <measurement group_id="O2" value="83.96" spread="15.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Depression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.07" spread="3.31"/>
                    <measurement group_id="O2" value="4.81" spread="4.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anxiety</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.99" spread="3.99"/>
                    <measurement group_id="O2" value="4.65" spread="3.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Baseline Caregiver Survey Response Rate, MD vs SC</title>
        <description>Number of caregivers who completed a baseline patient survey</description>
        <time_frame>Baseline</time_frame>
        <population>Caregivers who completed surveys</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Caregivers</title>
            <description>Multidisciplinary clinic informal caregivers of patients who are seen by multiple specialists at a single appointment time.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Caregivers</title>
            <description>Serial care control caregivers whose patients received the current system of linear, sequential, referral-based care delivery.</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Caregiver Survey Response Rate, MD vs SC</title>
          <description>Number of caregivers who completed a baseline patient survey</description>
          <population>Caregivers who completed surveys</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
                <count group_id="O2" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="100"/>
                    <measurement group_id="O2" value="144"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>3-month Caregiver Survey Response Rate, MD vs SC</title>
        <description>Number of caregivers who completed a 3-month survey</description>
        <time_frame>Within 30 days of 3 months after baseline survey administration</time_frame>
        <population>Caregivers who completed surveys</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Caregivers</title>
            <description>Multidisciplinary clinic informal caregivers of patients who are seen by multiple specialists at a single appointment time.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Caregivers</title>
            <description>Serial care control caregivers whose patients received the current system of linear, sequential, referral-based care delivery.</description>
          </group>
        </group_list>
        <measure>
          <title>3-month Caregiver Survey Response Rate, MD vs SC</title>
          <description>Number of caregivers who completed a 3-month survey</description>
          <population>Caregivers who completed surveys</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
                <count group_id="O2" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="62"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>6-Month Caregiver Survey Response Rate, MD vs SC</title>
        <description>Number of caregivers who completed a 6-month survey</description>
        <time_frame>Within 30 days of 6 months after baseline survey administration</time_frame>
        <population>Caregivers who completed surveys</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Caregivers</title>
            <description>Multidisciplinary clinic informal caregivers of patients who are seen by multiple specialists at a single appointment time.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Caregivers</title>
            <description>Serial care control caregivers whose patients received the current system of linear, sequential, referral-based care delivery.</description>
          </group>
        </group_list>
        <measure>
          <title>6-Month Caregiver Survey Response Rate, MD vs SC</title>
          <description>Number of caregivers who completed a 6-month survey</description>
          <population>Caregivers who completed surveys</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
                <count group_id="O2" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="66"/>
                    <measurement group_id="O2" value="113"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Caregiver Survey Scores at Baseline, MD vs SC</title>
        <description>Scores from caregiver surveys that measure quality of life and satisfaction with care received at the time the baseline survey was taken.
Overall quality of health care - satisfaction with overall quality of health care since lung cancer diagnosis; range:0-4 (higher is better) Treatment decision-making: Surgery/Radiation/Chemotherapy - each 1 item; satisfaction with treatment decision-making; range: 0-2 (0=patient controlled; 1=shared decision; 2-physician decision; closer to 1 is best) Treatment decision-making: family role - satisfaction with family role in treatment decision-making; range: 0-2 (0=patient controlled; 1=shared decision; 2-physician decision; closer to 1 is best) Satisfaction with treatment plan - satisfaction with overall treatment plan; range: 0-2 (higher is better) Satisfaction patient can complete treatment plan; range: 0-2 (higher is better) (continued in 3 month survey description)</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Caregivers</title>
            <description>Multidisciplinary clinic caregivers of patients seen by multiple specialists at a single appointment time.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Caregivers</title>
            <description>Serial care control caregivers of patients who receive the current system of linear, sequential, referral-based care delivery.</description>
          </group>
        </group_list>
        <measure>
          <title>Caregiver Survey Scores at Baseline, MD vs SC</title>
          <description>Scores from caregiver surveys that measure quality of life and satisfaction with care received at the time the baseline survey was taken.
Overall quality of health care - satisfaction with overall quality of health care since lung cancer diagnosis; range:0-4 (higher is better) Treatment decision-making: Surgery/Radiation/Chemotherapy - each 1 item; satisfaction with treatment decision-making; range: 0-2 (0=patient controlled; 1=shared decision; 2-physician decision; closer to 1 is best) Treatment decision-making: family role - satisfaction with family role in treatment decision-making; range: 0-2 (0=patient controlled; 1=shared decision; 2-physician decision; closer to 1 is best) Satisfaction with treatment plan - satisfaction with overall treatment plan; range: 0-2 (higher is better) Satisfaction patient can complete treatment plan; range: 0-2 (higher is better) (continued in 3 month survey description)</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
                <count group_id="O2" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Overall quality of health care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.27" spread="0.98"/>
                    <measurement group_id="O2" value="3.14" spread="0.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.78" spread="0.65"/>
                    <measurement group_id="O2" value="0.90" spread="0.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Radiation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.94" spread="0.69"/>
                    <measurement group_id="O2" value="1.03" spread="0.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Chemo</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.88" spread="0.59"/>
                    <measurement group_id="O2" value="0.98" spread="0.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Family role</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.68" spread="0.50"/>
                    <measurement group_id="O2" value="0.73" spread="0.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with treatment plan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.40" spread="0.83"/>
                    <measurement group_id="O2" value="1.61" spread="0.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction patient can complete treatment plan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.44" spread="0.80"/>
                    <measurement group_id="O2" value="1.63" spread="0.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with quality of care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.41" spread="2.57"/>
                    <measurement group_id="O2" value="13.90" spread="2.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with physician communication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.95" spread="2.48"/>
                    <measurement group_id="O2" value="18.76" spread="2.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with nurse communication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.96" spread="4.29"/>
                    <measurement group_id="O2" value="22.46" spread="3.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall team satisfaction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.66" spread="2.29"/>
                    <measurement group_id="O2" value="10.57" spread="2.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Depression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.12" spread="3.49"/>
                    <measurement group_id="O2" value="3.76" spread="3.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anxiety</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.57" spread="4.45"/>
                    <measurement group_id="O2" value="6.90" spread="4.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical Functioning QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.23" spread="27.38"/>
                    <measurement group_id="O2" value="77.24" spread="25.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical health problems QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.49" spread="38.46"/>
                    <measurement group_id="O2" value="68.71" spread="42.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.89" spread="26.14"/>
                    <measurement group_id="O2" value="80.32" spread="28.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>General health perceptions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.13" spread="19.63"/>
                    <measurement group_id="O2" value="69.35" spread="21.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Energy/Fatigue QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.66" spread="21.02"/>
                    <measurement group_id="O2" value="59.04" spread="20.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social Functioning QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.98" spread="26.60"/>
                    <measurement group_id="O2" value="76.97" spread="24.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emotional health problems QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.75" spread="40.15"/>
                    <measurement group_id="O2" value="72.77" spread="40.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emotional well-being QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.09" spread="22.96"/>
                    <measurement group_id="O2" value="68.33" spread="19.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Caregiver Survey Scores at 3 Months, MD vs SC</title>
        <description>Scores from caregiver surveys that measure quality of life and satisfaction with care received at the time the 3-month survey was taken.
(cont) Satisfaction with quality of care - overall satisfaction with care received from all care team members; range: 0-18 (sum of 6 items, higher is better) Satisfaction with physician communication - overall satisfaction with physician communication; range: 0-28 (sum of 7 items, higher is better) Satisfaction with nurse communication - overall satisfaction with nurse communication; range: 6-24 (sum of 6 items, higher is better) Overall team satisfaction - CAHPS satisfaction with care from team as a whole; range: 0-15 (sum of 4 items, higher is better) Depression/Anxiety - depression/anxiety measured by Hospital Anxiety and Depression Scale; range: 0-21 (sum of 7 items, higher is worse) (continued in 6 month survey description)</description>
        <time_frame>Within 30 days of 3 months after baseline survey administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Caregivers</title>
            <description>Multidisciplinary clinic caregivers of patients seen by multiple specialists at a single appointment time.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Caregivers</title>
            <description>Serial care control caregivers of patients who receive the current system of linear, sequential, referral-based care delivery.</description>
          </group>
        </group_list>
        <measure>
          <title>Caregiver Survey Scores at 3 Months, MD vs SC</title>
          <description>Scores from caregiver surveys that measure quality of life and satisfaction with care received at the time the 3-month survey was taken.
(cont) Satisfaction with quality of care - overall satisfaction with care received from all care team members; range: 0-18 (sum of 6 items, higher is better) Satisfaction with physician communication - overall satisfaction with physician communication; range: 0-28 (sum of 7 items, higher is better) Satisfaction with nurse communication - overall satisfaction with nurse communication; range: 6-24 (sum of 6 items, higher is better) Overall team satisfaction - CAHPS satisfaction with care from team as a whole; range: 0-15 (sum of 4 items, higher is better) Depression/Anxiety - depression/anxiety measured by Hospital Anxiety and Depression Scale; range: 0-21 (sum of 7 items, higher is worse) (continued in 6 month survey description)</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Overall quality of health care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.32" spread="0.96"/>
                    <measurement group_id="O2" value="3.55" spread="0.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.71" spread="0.69"/>
                    <measurement group_id="O2" value="1.08" spread="0.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Radiation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.90" spread="0.60"/>
                    <measurement group_id="O2" value="1.00" spread="0.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Chemo</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.78" spread="0.64"/>
                    <measurement group_id="O2" value="1.13" spread="0.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Family role</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.64" spread="0.53"/>
                    <measurement group_id="O2" value="0.75" spread="0.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with treatment plan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.80" spread="0.49"/>
                    <measurement group_id="O2" value="1.81" spread="0.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction patient can complete treatment plan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.86" spread="0.42"/>
                    <measurement group_id="O2" value="1.89" spread="0.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with quality of care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.82" spread="2.14"/>
                    <measurement group_id="O2" value="14.54" spread="2.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with physician communication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.30" spread="1.63"/>
                    <measurement group_id="O2" value="19.22" spread="2.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with nurse communication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.36" spread="1.66"/>
                    <measurement group_id="O2" value="23.28" spread="2.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall team satisfaction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.52" spread="0.89"/>
                    <measurement group_id="O2" value="11.46" spread="1.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Depression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.72" spread="3.10"/>
                    <measurement group_id="O2" value="3.04" spread="3.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anxiety</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.20" spread="4.10"/>
                    <measurement group_id="O2" value="6.04" spread="5.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical Functioning QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.92" spread="26.13"/>
                    <measurement group_id="O2" value="73.67" spread="27.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical health problems QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.37" spread="38.79"/>
                    <measurement group_id="O2" value="63.43" spread="42.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.37" spread="38.79"/>
                    <measurement group_id="O2" value="63.43" spread="42.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>General health perceptions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.90" spread="20.16"/>
                    <measurement group_id="O2" value="69.14" spread="20.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Energy/Fatigue QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.70" spread="18.30"/>
                    <measurement group_id="O2" value="58.30" spread="16.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social Functioning QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.60" spread="27.08"/>
                    <measurement group_id="O2" value="80.19" spread="23.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emotional health problems QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.67" spread="40.76"/>
                    <measurement group_id="O2" value="67.28" spread="43.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emotional well-being QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.37" spread="14.61"/>
                    <measurement group_id="O2" value="67.80" spread="20.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Caregiver Survey Scores at 6 Months, MD vs SC</title>
        <description>Scores from caregiver surveys that measure quality of life and satisfaction with care received at the time the 6-month survey was taken.
(cont) Physical Functioning QOL - 10 items; Physical Health Problems QOL - 4 items; Pain QOL - 2 items; General health perceptions - 5 items; Energy/fatigue QOL - 4 items; Social Functioning QOL - 2 items; Emotional health problems QOL - 3 items; Emotional well-being QOL - 5 items.
All health related quality of life measures are from the SF-36 survey tool, and use a range of 0-100 mean score (higher is better).</description>
        <time_frame>Within 30 days of 6 months after baseline survey administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Caregivers</title>
            <description>Multidisciplinary clinic caregivers of patients seen by multiple specialists at a single appointment time.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Caregivers</title>
            <description>Serial care control caregivers of patients who receive the current system of linear, sequential, referral-based care delivery.</description>
          </group>
        </group_list>
        <measure>
          <title>Caregiver Survey Scores at 6 Months, MD vs SC</title>
          <description>Scores from caregiver surveys that measure quality of life and satisfaction with care received at the time the 6-month survey was taken.
(cont) Physical Functioning QOL - 10 items; Physical Health Problems QOL - 4 items; Pain QOL - 2 items; General health perceptions - 5 items; Energy/fatigue QOL - 4 items; Social Functioning QOL - 2 items; Emotional health problems QOL - 3 items; Emotional well-being QOL - 5 items.
All health related quality of life measures are from the SF-36 survey tool, and use a range of 0-100 mean score (higher is better).</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Overall quality of health care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.24" spread="0.87"/>
                    <measurement group_id="O2" value="3.23" spread="0.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.05" spread="0.67"/>
                    <measurement group_id="O2" value="0.91" spread="0.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Radiation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.05" spread="0.83"/>
                    <measurement group_id="O2" value="0.88" spread="0.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Chemo</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.03" spread="0.68"/>
                    <measurement group_id="O2" value="1.00" spread="0.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment decision-making: Family role</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.78" spread="0.49"/>
                    <measurement group_id="O2" value="0.76" spread="0.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with treatment plan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.79" spread="0.48"/>
                    <measurement group_id="O2" value="1.86" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction patient can complete treatment plan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.78" spread="0.58"/>
                    <measurement group_id="O2" value="1.72" spread="0.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with quality of care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.33" spread="2.20"/>
                    <measurement group_id="O2" value="14.14" spread="2.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with physician communication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.27" spread="2.41"/>
                    <measurement group_id="O2" value="19.50" spread="1.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with nurse communication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.88" spread="3.50"/>
                    <measurement group_id="O2" value="23.36" spread="1.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall team satisfaction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.27" spread="1.42"/>
                    <measurement group_id="O2" value="11.73" spread="0.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Depression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.97" spread="2.89"/>
                    <measurement group_id="O2" value="3.45" spread="2.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anxiety</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.42" spread="3.67"/>
                    <measurement group_id="O2" value="5.23" spread="3.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical Functioning QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.15" spread="28.84"/>
                    <measurement group_id="O2" value="79.67" spread="25.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical health problems QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.48" spread="41.43"/>
                    <measurement group_id="O2" value="69.32" spread="46.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.44" spread="25.41"/>
                    <measurement group_id="O2" value="84.66" spread="28.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>General health perceptions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.09" spread="17.30"/>
                    <measurement group_id="O2" value="62.95" spread="21.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Energy/Fatigue QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.75" spread="22.51"/>
                    <measurement group_id="O2" value="54.85" spread="15.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social Functioning QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.59" spread="24.15"/>
                    <measurement group_id="O2" value="80.91" spread="24.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emotional health problems QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.73" spread="40.36"/>
                    <measurement group_id="O2" value="74.24" spread="42.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emotional well-being QOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.60" spread="18.43"/>
                    <measurement group_id="O2" value="63.33" spread="18.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Timeliness of Care, MD vs SC</title>
        <description>Aggregate time in days from enrollment to a specific care delivery endpoint including: from initial detection of lesion to initial biopsy, from initial detection to non-invasive staging, from initial detection to invasive staging, and from initial detection to definitive treatment. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
        <time_frame>From the time of a patient's initial lesion detection to the designated step in the care process, as noted per row below</time_frame>
        <population>Not every patient went to every step, therefore the times only include patients that completed that step.</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients</title>
            <description>Patients seen and treated in the standard, sequential-referral-based environment of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Timeliness of Care, MD vs SC</title>
          <description>Aggregate time in days from enrollment to a specific care delivery endpoint including: from initial detection of lesion to initial biopsy, from initial detection to non-invasive staging, from initial detection to invasive staging, and from initial detection to definitive treatment. 2 group comparison between Multidisciplinary Clinic Patients and Serial Care Patients.</description>
          <population>Not every patient went to every step, therefore the times only include patients that completed that step.</population>
          <units>Days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="178"/>
                <count group_id="O2" value="348"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>From Initial detection of lesion to initial biopsy</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="123"/>
                    <count group_id="O2" value="207"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25" lower_limit="9" upper_limit="71"/>
                    <measurement group_id="O2" value="15" lower_limit="4" upper_limit="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>From initial detection to non-invasive staging</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="169"/>
                    <count group_id="O2" value="301"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="8" upper_limit="44"/>
                    <measurement group_id="O2" value="16" lower_limit="3" upper_limit="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>From initial detection to invasive staging</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="93"/>
                    <count group_id="O2" value="136"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29" lower_limit="16" upper_limit="79"/>
                    <measurement group_id="O2" value="20" lower_limit="6" upper_limit="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>From initial detection to definitive treatment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="156"/>
                    <count group_id="O2" value="288"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60" lower_limit="41" upper_limit="139"/>
                    <measurement group_id="O2" value="57" lower_limit="33" upper_limit="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Time from Initial Detection of Lesion to Diagnostic Biopsy</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0042</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Time from Initial Detection of Lesion to Non-invasive Staging Test</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0805</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Time from Initial Detection of Lesion to Invasive Staging Test</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0073</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Time from Initial Detection of Lesion to Definitive Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0579</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Timeliness of Care, MD vs SC (Conference) vs SC (no Conference)</title>
        <description>Aggregate time in days from enrollment to specific care delivery endpoint including: from initial detection of lesion to initial biopsy, from initial detection to non-invasive staging, from initial detection to invasive staging, and from initial detection to definitive treatment.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
        <time_frame>From the time of a patient's initial lesion detection to the designated step in the care process, as noted per row below</time_frame>
        <population>Not every patient went to every step, therefore the times only include patients that completed that step.</population>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients Presented in Conference</title>
            <description>Serial care patients who were presented in the multidisciplinary conference but not seen in the multidisciplinary clinic.</description>
          </group>
          <group group_id="O3">
            <title>Serial Care Patients Not Presented in Conference</title>
            <description>Serial care patients who were not presented in the multidisciplinary conference.</description>
          </group>
        </group_list>
        <measure>
          <title>Timeliness of Care, MD vs SC (Conference) vs SC (no Conference)</title>
          <description>Aggregate time in days from enrollment to specific care delivery endpoint including: from initial detection of lesion to initial biopsy, from initial detection to non-invasive staging, from initial detection to invasive staging, and from initial detection to definitive treatment.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
          <population>Not every patient went to every step, therefore the times only include patients that completed that step.</population>
          <units>Days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="178"/>
                <count group_id="O2" value="76"/>
                <count group_id="O3" value="272"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>From Initial detection of lesion to initial biopsy</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="123"/>
                    <count group_id="O2" value="50"/>
                    <count group_id="O3" value="272"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25" lower_limit="9" upper_limit="71"/>
                    <measurement group_id="O2" value="18.5" lower_limit="4" upper_limit="40"/>
                    <measurement group_id="O3" value="13" lower_limit="4" upper_limit="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>From initial detection to non-invasive staging</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="169"/>
                    <count group_id="O2" value="67"/>
                    <count group_id="O3" value="272"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="8" upper_limit="44"/>
                    <measurement group_id="O2" value="18" lower_limit="6" upper_limit="40"/>
                    <measurement group_id="O3" value="16" lower_limit="3" upper_limit="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Initial detection of lesion to invasive staging</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="93"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="96"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29" lower_limit="16" upper_limit="79"/>
                    <measurement group_id="O2" value="40" lower_limit="9" upper_limit="80"/>
                    <measurement group_id="O3" value="14" lower_limit="5" upper_limit="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>From initial detection to definitive treatment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="156"/>
                    <count group_id="O2" value="66"/>
                    <count group_id="O3" value="222"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60" lower_limit="41" upper_limit="139"/>
                    <measurement group_id="O2" value="69" lower_limit="44" upper_limit="160"/>
                    <measurement group_id="O3" value="54" lower_limit="30" upper_limit="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Time from Initial Detection of Lesion to Diagnostic Biopsy</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0146</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Time from Initial Detection of Lesion to Non-invasive Staging Test</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.16</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Time from Initial Detection of Lesion to Invasive Staging Test</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0014</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Time from Initial Detection of Lesion to Definitive Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0037</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Clinical Provider Survey Responses - Ease of Referring Patients to the Conference</title>
        <description>Responses from clinical providers will measure provider satisfaction and obstacles to institutional multidisciplinary care.</description>
        <time_frame>After a provider referred their 5th patient to the multidisciplinary conference (baseline), then within 30 days of 6 months and 12 months, respectively, after baseline survey was completed</time_frame>
        <population>Any clinical provider who referred at least 5 patients to the multidisciplinary program and consented to take satisfaction surveys.</population>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Clinical providers who referred more than 5 patients to the multidisciplinary program</description>
          </group>
          <group group_id="O2">
            <title>6 Month Follow up</title>
            <description>6-month follow up of clinical providers who referred more than 5 patients to the multidisciplinary program</description>
          </group>
          <group group_id="O3">
            <title>12 Month Follow-up</title>
            <description>12 month follow up of clinical providers who referred more than 5 patients to the multidisciplinary program</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Provider Survey Responses - Ease of Referring Patients to the Conference</title>
          <description>Responses from clinical providers will measure provider satisfaction and obstacles to institutional multidisciplinary care.</description>
          <population>Any clinical provider who referred at least 5 patients to the multidisciplinary program and consented to take satisfaction surveys.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Very Satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Somewhat satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Somewhat dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Clinical Provider Survey Responses - How Quickly my Patients Get Scheduled to be Discussed at the Conference</title>
        <description>Responses from clinical providers will measure provider satisfaction and obstacles to institutional multidisciplinary care.</description>
        <time_frame>After a provider referred their 5th patient to the multidisciplinary conference (baseline), then within 30 days of 6 months and 12 months, respectively, after baseline survey was completed</time_frame>
        <population>Any clinical provider who referred at least 5 patients to the multidisciplinary program and consented to take satisfaction surveys.</population>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Clinical providers who referred more than 5 patients to the multidisciplinary program</description>
          </group>
          <group group_id="O2">
            <title>6 Month Follow up</title>
            <description>6-month follow up of clinical providers who referred more than 5 patients to the multidisciplinary program</description>
          </group>
          <group group_id="O3">
            <title>12 Month Follow-up</title>
            <description>12 month follow up of clinical providers who referred more than 5 patients to the multidisciplinary program</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Provider Survey Responses - How Quickly my Patients Get Scheduled to be Discussed at the Conference</title>
          <description>Responses from clinical providers will measure provider satisfaction and obstacles to institutional multidisciplinary care.</description>
          <population>Any clinical provider who referred at least 5 patients to the multidisciplinary program and consented to take satisfaction surveys.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Very satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Somewhat satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Clinical Provider Survey Responses - The Helpfulness of the Staff in Scheduling Patients</title>
        <description>Responses from clinical providers will measure provider satisfaction and obstacles to institutional multidisciplinary care.</description>
        <time_frame>After a provider referred their 5th patient to the multidisciplinary conference (baseline), then within 30 days of 6 months and 12 months, respectively, after baseline survey was completed</time_frame>
        <population>Any clinical provider who referred at least 5 patients to the multidisciplinary program and consented to take satisfaction surveys.</population>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Clinical providers who referred more than 5 patients to the multidisciplinary program</description>
          </group>
          <group group_id="O2">
            <title>6 Month Follow up</title>
            <description>6-month follow up of clinical providers who referred more than 5 patients to the multidisciplinary program</description>
          </group>
          <group group_id="O3">
            <title>12 Month Follow-up</title>
            <description>12 month follow up of clinical providers who referred more than 5 patients to the multidisciplinary program</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Provider Survey Responses - The Helpfulness of the Staff in Scheduling Patients</title>
          <description>Responses from clinical providers will measure provider satisfaction and obstacles to institutional multidisciplinary care.</description>
          <population>Any clinical provider who referred at least 5 patients to the multidisciplinary program and consented to take satisfaction surveys.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Very Satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Somewhat satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Somewhat dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Clinical Provider Survey Responses - The Quality of Treatment Recommendations That I Received for my Patient</title>
        <description>Responses from clinical providers will measure provider satisfaction and obstacles to institutional multidisciplinary care.</description>
        <time_frame>After a provider referred their 5th patient to the multidisciplinary conference (baseline), then within 30 days of 6 months and 12 months, respectively, after baseline survey was completed</time_frame>
        <population>Any clinical provider who referred at least 5 patients to the multidisciplinary program and consented to take satisfaction surveys.</population>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Clinical providers who referred more than 5 patients to the multidisciplinary program</description>
          </group>
          <group group_id="O2">
            <title>6 Month Follow up</title>
            <description>6-month follow up of clinical providers who referred more than 5 patients to the multidisciplinary program</description>
          </group>
          <group group_id="O3">
            <title>12 Month Follow-up</title>
            <description>12 month follow up of clinical providers who referred more than 5 patients to the multidisciplinary program</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Provider Survey Responses - The Quality of Treatment Recommendations That I Received for my Patient</title>
          <description>Responses from clinical providers will measure provider satisfaction and obstacles to institutional multidisciplinary care.</description>
          <population>Any clinical provider who referred at least 5 patients to the multidisciplinary program and consented to take satisfaction surveys.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Very Satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Somewhat satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Somewhat dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Clinical Provider Survey Responses - How Quickly I Receive Feedback on my Patient</title>
        <description>Responses from clinical providers will measure provider satisfaction and obstacles to institutional multidisciplinary care.</description>
        <time_frame>After a provider referred their 5th patient to the multidisciplinary conference (baseline), then within 30 days of 6 months and 12 months, respectively, after baseline survey was completed</time_frame>
        <population>Any clinical provider who referred at least 5 patients to the multidisciplinary program and consented to take satisfaction surveys.</population>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Clinical providers who referred more than 5 patients to the multidisciplinary program</description>
          </group>
          <group group_id="O2">
            <title>6 Month Follow up</title>
            <description>6-month follow up of clinical providers who referred more than 5 patients to the multidisciplinary program</description>
          </group>
          <group group_id="O3">
            <title>12 Month Follow-up</title>
            <description>12 month follow up of clinical providers who referred more than 5 patients to the multidisciplinary program</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Provider Survey Responses - How Quickly I Receive Feedback on my Patient</title>
          <description>Responses from clinical providers will measure provider satisfaction and obstacles to institutional multidisciplinary care.</description>
          <population>Any clinical provider who referred at least 5 patients to the multidisciplinary program and consented to take satisfaction surveys.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Very Satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Somewhat satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Clinical Provider Survey Responses - The Consistency With Which my Patients Are Sent Back for Further Treatment</title>
        <description>Responses from clinical providers will measure provider satisfaction and obstacles to institutional multidisciplinary care.</description>
        <time_frame>After a provider referred their 5th patient to the multidisciplinary conference (baseline), then within 30 days of 6 months and 12 months, respectively, after baseline survey was completed</time_frame>
        <population>Any clinical provider who referred at least 5 patients to the multidisciplinary program and consented to take satisfaction surveys.</population>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Clinical providers who referred more than 5 patients to the multidisciplinary program</description>
          </group>
          <group group_id="O2">
            <title>6 Month Follow up</title>
            <description>6-month follow up of clinical providers who referred more than 5 patients to the multidisciplinary program</description>
          </group>
          <group group_id="O3">
            <title>12 Month Follow-up</title>
            <description>12 month follow up of clinical providers who referred more than 5 patients to the multidisciplinary program</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Provider Survey Responses - The Consistency With Which my Patients Are Sent Back for Further Treatment</title>
          <description>Responses from clinical providers will measure provider satisfaction and obstacles to institutional multidisciplinary care.</description>
          <population>Any clinical provider who referred at least 5 patients to the multidisciplinary program and consented to take satisfaction surveys.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Very Satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Somewhat satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Somewhat dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>N/A</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Patient Overall Survival</title>
        <description>Overall survival, defined as the time from cancer diagnosis to death from any cause or data censoring, is analyzed and summarized with the survival probabilities over time using the Kaplan-Meier method. Confidence intervals for the 1- and 3- year survival probabilities are reported. Additionally, the Cox proportional hazard model was used to estimate hazard ratios which are reported in the statistical analyses with 95% confidence intervals.</description>
        <time_frame>As measured from the time from cancer diagnosis to death or data censor, up to 6 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>150 multidisciplinary clinic patients and their informal caregivers are seen by multiple specialists at a single appointment time.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients</title>
            <description>300 matched serial care control patients who receive the current system of linear, sequential, referral-based care delivery.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Overall Survival</title>
          <description>Overall survival, defined as the time from cancer diagnosis to death from any cause or data censoring, is analyzed and summarized with the survival probabilities over time using the Kaplan-Meier method. Confidence intervals for the 1- and 3- year survival probabilities are reported. Additionally, the Cox proportional hazard model was used to estimate hazard ratios which are reported in the statistical analyses with 95% confidence intervals.</description>
          <units>survival probability</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="178"/>
                <count group_id="O2" value="348"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1-year overall survival estimate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.58" lower_limit="0.51" upper_limit="0.65"/>
                    <measurement group_id="O2" value="0.60" lower_limit="0.54" upper_limit="0.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-year overall survival estimate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.34" lower_limit="0.27" upper_limit="0.41"/>
                    <measurement group_id="O2" value="0.36" lower_limit="0.31" upper_limit="0.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7506</p_value>
            <method>Log Rank</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.54</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.08</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.85</ci_lower_limit>
            <ci_upper_limit>1.36</ci_upper_limit>
            <estimate_desc>Comparison is Multidisciplinary/Serial Care.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Patient Overall Survival With SC Further Broken Down</title>
        <description>Overall survival, defined as the time from cancer diagnosis to death from any cause or data censoring, is analyzed and summarized with the survival probabilities over time using the Kaplan-Meier method. Confidence intervals for the 1- and 3- year survival probabilities are reported. Additionally, the Cox proportional hazard model was used to estimate hazard ratios which are reported in the statistical analyses with 95% confidence intervals.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
        <time_frame>As measured from the time from cancer diagnosis to death or data censor, up to 6 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients Presented in Conference</title>
            <description>Serial care patients who were presented in the multidisciplinary conference but not seen in the multidisciplinary clinic.</description>
          </group>
          <group group_id="O3">
            <title>Serial Care Patients Not Presented in Conference</title>
            <description>Serial care patients who were not presented in the multidisciplinary conference.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Overall Survival With SC Further Broken Down</title>
          <description>Overall survival, defined as the time from cancer diagnosis to death from any cause or data censoring, is analyzed and summarized with the survival probabilities over time using the Kaplan-Meier method. Confidence intervals for the 1- and 3- year survival probabilities are reported. Additionally, the Cox proportional hazard model was used to estimate hazard ratios which are reported in the statistical analyses with 95% confidence intervals.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
          <units>survival probability</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="178"/>
                <count group_id="O2" value="76"/>
                <count group_id="O3" value="272"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1-year overall survival estimate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.58" lower_limit="0.51" upper_limit="0.65"/>
                    <measurement group_id="O2" value="0.64" lower_limit="0.53" upper_limit="0.74"/>
                    <measurement group_id="O3" value="0.58" lower_limit="0.52" upper_limit="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-year overall survival estimate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.34" lower_limit="0.27" upper_limit="0.41"/>
                    <measurement group_id="O2" value="0.41" lower_limit="0.30" upper_limit="0.52"/>
                    <measurement group_id="O3" value="0.34" lower_limit="0.29" upper_limit="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4847</p_value>
            <method>Log Rank</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.51</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.12</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.87</ci_lower_limit>
            <ci_upper_limit>1.43</ci_upper_limit>
            <estimate_desc>Comparison is Multidisciplinary/Serial Care Patients Not Presented in Conference</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.51</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.19</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.84</ci_lower_limit>
            <ci_upper_limit>1.67</ci_upper_limit>
            <estimate_desc>Comparison is Serial Care Patients Presented in Conference/Serial Care Patients Not Presented in Conference</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Patient Disease/Progression Free Survival</title>
        <description>Event-free survival (EFS), as measured from the time from cancer diagnosis to disease progression, death, or data censoring, is analyzed and summarized with the survival probabilities over time using the Kaplan-Meier method. Confidence intervals for the 1- and 3- year survival probabilities are reported. Additionally, the Cox proportional hazard model was used to estimate hazard ratios which are reported in the statistical analyses with 95% confidence intervals.</description>
        <time_frame>measured from the time from cancer diagnosis to disease progression, death, or data censoring, up to 6 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>150 multidisciplinary clinic patients and their informal caregivers are seen by multiple specialists at a single appointment time.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients</title>
            <description>300 matched serial care control patients who receive the current system of linear, sequential, referral-based care delivery.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Disease/Progression Free Survival</title>
          <description>Event-free survival (EFS), as measured from the time from cancer diagnosis to disease progression, death, or data censoring, is analyzed and summarized with the survival probabilities over time using the Kaplan-Meier method. Confidence intervals for the 1- and 3- year survival probabilities are reported. Additionally, the Cox proportional hazard model was used to estimate hazard ratios which are reported in the statistical analyses with 95% confidence intervals.</description>
          <units>survival probability</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="178"/>
                <count group_id="O2" value="348"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1-year EFS survival estimate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.45" lower_limit="0.38" upper_limit="0.53"/>
                    <measurement group_id="O2" value="0.48" lower_limit="0.43" upper_limit="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-year EFS survival estimate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.26" lower_limit="0.20" upper_limit="0.33"/>
                    <measurement group_id="O2" value="0.26" lower_limit="0.21" upper_limit="0.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9874</p_value>
            <method>Log Rank</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.80</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.03</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.82</ci_lower_limit>
            <ci_upper_limit>1.29</ci_upper_limit>
            <estimate_desc>Comparison is Multidisciplinary/Serial Care</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Patient Disease/Progression Free Survival With SC Further Broken Down</title>
        <description>Event-free survival (EFS), as measured from the time from cancer diagnosis to disease progression, death, or data censoring, is analyzed and summarized with the survival probabilities over time using the Kaplan-Meier method. Confidence intervals for the 1- and 3- year survival probabilities are reported. Additionally, the Cox proportional hazard model was used to estimate hazard ratios which are reported in the statistical analyses with 95% confidence intervals.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
        <time_frame>As measured from the time from cancer diagnosis to death or data censor, up to 6 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Multidisciplinary Clinic Patients</title>
            <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
          </group>
          <group group_id="O2">
            <title>Serial Care Patients Presented in Conference</title>
            <description>Serial care patients who were presented in the multidisciplinary conference but not seen in the multidisciplinary clinic.</description>
          </group>
          <group group_id="O3">
            <title>Serial Care Patients Not Presented in Conference</title>
            <description>Serial care patients who were not presented in the multidisciplinary conference.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Disease/Progression Free Survival With SC Further Broken Down</title>
          <description>Event-free survival (EFS), as measured from the time from cancer diagnosis to disease progression, death, or data censoring, is analyzed and summarized with the survival probabilities over time using the Kaplan-Meier method. Confidence intervals for the 1- and 3- year survival probabilities are reported. Additionally, the Cox proportional hazard model was used to estimate hazard ratios which are reported in the statistical analyses with 95% confidence intervals.
This measure compares 3 groups, instead of 2, because some patients in the serial care group were presented for discussion in a multidisciplinary thoracic oncology conference while still not being seen in the multidisciplinary clinic setting. Therefore, we split the serial care group in two in order to measure the potential impact of a multidisciplinary conference model, separate from the multidisciplinary clinic model.</description>
          <units>survival probability</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="178"/>
                <count group_id="O2" value="76"/>
                <count group_id="O3" value="272"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1-year EFS survival estimate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.45" lower_limit="0.38" upper_limit="0.53"/>
                    <measurement group_id="O2" value="0.55" lower_limit="0.43" upper_limit="0.65"/>
                    <measurement group_id="O3" value="0.46" lower_limit="0.40" upper_limit="0.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-year EFS survival estimate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.26" lower_limit="0.20" upper_limit="0.33"/>
                    <measurement group_id="O2" value="0.32" lower_limit="0.22" upper_limit="0.43"/>
                    <measurement group_id="O3" value="0.24" lower_limit="0.19" upper_limit="0.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5377</p_value>
            <method>Log Rank</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.73</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.06</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.83</ci_lower_limit>
            <ci_upper_limit>1.34</ci_upper_limit>
            <estimate_desc>Comparison is Multidisciplinary/Serial Care Patients Not Presented in Conference</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.73</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.13</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.82</ci_lower_limit>
            <ci_upper_limit>1.57</ci_upper_limit>
            <estimate_desc>Comparison is Serial Care Patients Presented in Conference/Serial Care Patients Not Presented in Conference</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>All-cause mortality for patients included a median follow up time of at least 1.5 years, up to 6 years in total.</time_frame>
      <desc>All-cause mortality was defined as the occurrence of death due to any cause. All-cause mortality for caregivers and clinical providers were not monitored.
Serious and Other (Not Including Serious) Adverse Events were not monitored or assessed for patients, caregivers, or clinical providers.
All-cause mortality reported is beyond the initial 6 month period noted in the participant flow table.</desc>
      <group_list>
        <group group_id="E1">
          <title>Multidisciplinary Clinic Patients</title>
          <description>Patients seen and treated in the Multidisciplinary Clinic.</description>
        </group>
        <group group_id="E2">
          <title>Serial Care Patients</title>
          <description>Patients seen and treated in the standard, sequential-referral-based environment of care.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="125" subjects_at_risk="178"/>
                <counts group_id="E2" subjects_affected="239" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Raymond Osarogiagbon</name_or_title>
      <organization>Baptist Cancer Center</organization>
      <phone>901-752-6131</phone>
      <email>Raymond.Osarogiagbon@bmg.md</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

